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Lung carcinomas and pulmonary ﬁbrosis (asbestosis) occur in asbestos workers.
Understanding the pathogenesis of these diseases is complicated because of potential con-
founding factors, such as smoking, which is not a risk factor in mesothelioma. The modes
of action (MOA) of various types of asbestos in the development of lung cancers, asbestosis,
and mesotheliomas appear to be different. Moreover, asbestos ﬁbers may act differentially
at various stages of these diseases, and have different potencies as compared to other natu-
rally occurring and synthetic ﬁbers. This literature review describes patterns of deposition
and retention of various types of asbestos and other ﬁbers after inhalation, methods of
translocation within the lung, and dissolution of various ﬁber types in lung compartments
and cells in vitro. Comprehensive dose-response studies at ﬁber concentrations inhaled by
humans as well as bivariate size distributions (lengths and widths), types, and sources of
ﬁbers are rarely deﬁned in published studies and are needed. Species-speciﬁc responses may
occur. Mechanistic studies have some of these limitations, but have suggested that changes in
gene expression (either ﬁber-catalyzed directly or by cell elaboration of oxidants), epigenetic
changes, and receptor-mediated or other intracellular signaling cascades may play roles in
various stages of the development of lung cancers or asbestosis.
In addition to malignant mesotheliomas
(MM), two pulmonary diseases linked to
exposure to asbestos ﬁbers in the workplace
are lung carcinomas and asbestosis. Asbestos
exposure is less of a risk factor than smoking
*This author has disclosed a potential conﬂict of interest as described by one or more of the following: He/She has acted and/or
is currently acting as an expert witness or consultant for law ﬁrms representing plaintiffs and/or defendants in asbestos litigation and
compensation board proceedings, and has been a paid or unpaid consultant to regulatory and medical agencies and compensation
boards in North America, including but not limited to NIEHS, EPA, ATSDR, ATS, NGOs and individual and collective citizen groups
concerned with asbestos exposure and disease.
#This author has disclosed a potential conﬂict of interest as described by one or more of the following: He/She may have also
received (and may also apply in future for) competitive-funding research grants from U.S. publicly ﬁnanced, peer-reviewed grant approval
process agencies concerning asbestos exposure and disease, including topics covered in all aspects of the workshop, including but not
limited to research support from NIEHS.
We appreciate the comments and editing of Drs. Gene McConnell, Annie Jarabek, David Bernstein, Arnold Brody, and Maureen
Gwinn. We thank Jennifer Díaz (Department of Pathology, UVM) for multiple revisions to this paper.
Address correspondence to Brooke T. Mossman, University of Vermont College of Medicine, Department of Pathology, 89 Beaumont
Avenue, Burlington, VT 05405, USA. E-mail: brooke.mossman@uvm.edu
in the causation of lung carcinomas (Selikoff
et al., 1968). However, the incidence of lung
cancers increases additively or synergistically
in asbestos workers who smoke, and depends
upon the cohort (Mossman & Gee, 1989;
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Saracci, 1987; McDonald & McDonald, 1987).
Historically, some investigators reported that
adenocarcinomas and tumors developing in
the lower, peripheral lung lobes are most
commonly seen in asbestos-exposed lung
cancer patients (Soutar et al., 1974; Weiss,
2000). The predominant hypothesis put forth is
that pulmonary ﬁbrosis (asbestosis) arises in the
peripheral lung at sites of deposition of asbestos
ﬁbers and creates a favorable environment for
development of lung cancers. Proliferating lung
ﬁbroblasts in these lesions may promote pro-
liferation or metaplasia of lung epithelial cells
throughelaborationofgrowthfactorsorcell–cell
communication (Mossman & Churg, 1998).
Some studies also suggest that there is an
increasedriskforlung cancerinindividualswith
clinical asbestosis, whereas others speculate the
asbestosisandasbestos-inducedlungcancerare
independent processes (Kannerstein & Churg,
1972; Rom, 1998; Haus et al., 2001). Cigarette
smoke may also be a risk factor or may exacer-
batethepathogenesisofasbestosis(Weiss,1984;
ATS 2004).
This report describes the patterns of depo-
sition and retention of various types of ﬁbers
after inhalation, mechanisms of translocation
within the lung, and dissolution of various ﬁber
types both in lung compartments and in assays
in vitro. Much of the report also focuses on
mechanisms of action of asbestos ﬁbers, as sug-
gested by studies using in vitro models, analyses
of human lungs, and inhalation experiments
using rodents. Investigations in which ﬁbers
were administered by intratracheal instillation
or pharyngeal administration or studies where
asbestos ﬁbers have been injected into the
lung are not discussed because of their artiﬁcial
nature, bypassing of normal clearance mecha-
nisms, and association with lung overload.
DEPOSITION AND TRANSLOCATION
OF ASBESTOS FIBERS IN THE LUNG
Fiber Deposition in the Respiratory Tract
Differences in airway anatomy and archi-
tecture occur as a result of age, interspecies
variations, and other factors that inﬂuence ﬁber
deposition. There are ﬁve mechanisms that are
important with respect to the deposition of
ﬁbers in respiratory tract airways. These are
interception, impaction, sedimentation, diffu-
sion, and electrostatic precipitation. The rela-
tive contribution of each of these mechanisms
varies in different regions of the respiratory
tract (Figure 1). Interception, a mechanism by
which deposition occurs when the ends of
the inhaled ﬁbers intersect with the airway
architecture, is an important mechanism of
deposition for ﬁbers, especially in the upper
respiratory tract and at initial bifurcations of
the tracheobronchial tree, where inhaled air-
ﬂow is at a high velocity and encounters large
directional changes. Impaction occurs when
the inertia of the ﬁber forces it out of the
airstream (Stöber et al., 1970; Timbrell, 1972).
Most impaction occurs downstream of air jets
in the larger airways, where the ﬂow veloc-
ities are high and the momentum of a ﬁber
propels it out of the bending ﬂow streamlines
FIGURE 1. Fiber deposition in the lung. Lines within the airways show net axial core ﬂow through the trachea (site of impaction), bronchi,
and bronchioles (Lippmann & Schlesinger 1984).78 B. T. MOSSMAN ET AL.
and onto relatively small portions of the epithe-
lial surfaces (Balashazy et al., 2005; Su &
Cheng, 2006). Sedimentation, whereby the
ﬁber deposits due to gravitational forces, is
favored by low ﬂow velocity, long residence
times, and smaller airway sizes. Interception,
impaction, and sedimentation probabilities are
governed by the aerodynamic diameter of the
ﬁbers, which, for long mineral ﬁbers, may
be estimated as approximately three times
their physical diameters (Stöber et al.,1970;
Timbrell, 1972). However, it needs to be noted
that the term aerodynamic “diameter” is a
misnomer for ﬁbers since both the length
and width of a ﬁber determine its aerody-
namic behavior (Cheng, 1986; Vincent, 2005).
Aerodynamic equivalent (def) is deﬁned as a
function of the bivariate distribution (Cheng,
1986). Further, it has become an almost univer-
sal convention that ﬁbers need to be assessed
in terms of their number concentration, and
need to be selected according to criteria that
relate to shape and dimensions when ﬁbers are
collected on a membrane ﬁlter and viewed by
microscopy for dimensional measurement post
air sampling (Vincent, 2005). Different deﬁni-
tions of “respirable ﬁbers” may exist. For exam-
ple, a respirable ﬁber is deﬁned by NIOSH
(NIOSH 7400) as one with length (lf) greater
than 5 µm and aspect ratio (lf/df) ≥3, where
df is ﬁber width. The Asbestos International
Association (AIA) criteria specify that, in addi-
tion to lf >5 µma n dl f /df ≥3, the df should be
<3 µm.
Diffusional displacement results from colli-
sions between air molecules and airborne par-
ticles. For compact particles, diffusion becomes
an important deposition mechanism for diame-
ters smaller than about 0.5 µm. Fibers of similar
diameter would be more massive and therefore
be displaced less by a single molecular impact.
Long ﬁbers may have millions of impacts from
air molecules, and their random trajectories
may tend to damp the net displacement. In
contrast, a single collision near a ﬁber end may
rotate the ﬁber sufﬁciently to alter its intercep-
tion probability. The role of diffusion in ﬁber
deposition is poorly understood. Gentry et al.
(1983) measured the diffusion coefﬁcients of
chrysotile and crocidolite asbestos ﬁbers and
found good agreement with theoretical predic-
tions for chrysotile (0.4 µmm e a nd i a m e t e r )
but poor agreement with the more rod-like
crocidolite (0.3 µm mean diameter).
Electrostatic precipitation occurs when
charged particles induce opposite changes
on airway surfaces and is dependent on the
ratio of electrical charge to aerodynamic drag.
Jones et al. (1983) showed that asbestos ﬁber
processing operations generate ﬁbrous aerosols
with relatively high charge levels, and that
these charge levels are sufﬁcient to produce an
enhancement of ﬁber deposition in the lungs.
Such an enhancement of ﬁber deposition
for chrysotile asbestos was seen in rats that
were exposed by inhalation (Davis, 1976).
Interception increases with ﬁber length. The
greater the length, the more likely it is that the
position of a ﬁber end will cause it to touch
a surface that the center of mass would have
missed.
Obviously, the dimensions of the airway
architecture in different species interact with
these mechanisms of deposition of the inhaled
ﬁbers to deﬁne deposition efﬁciency in the
various regions of the respiratory tract. The
conductive airway region of the human lung
consists of a series of bifurcating airways with
the daughter airways being of nearly equal size.
In contrast, bifurcations in animal lungs lead to
daughter airways of different sizes. The major
daughter airway is only slightly smaller than
the parent airway, and the smaller daughters
resemble side branches. In the human lung,
the trachea is the only airway segment with a
length-to-diameter ratio much greater than 3.
Single symmetrical ﬁbers suspended in a lam-
inar ﬂow stream tend to become aligned with
the ﬂow axis as they move through a lung air-
way. On the contrary, ﬁber agglomerates or
nonﬁbrous particles would have more random
orientations that would depend on their dis-
tributions of masses and drag forces. A ﬁber
whose ﬂow orientation differs from axial align-
ment would have an enhanced probability of
deposition by interception.
A ﬁber’s alignment is radically altered as
it enters a daughter airway in the human
lung, and this loss of alignment with the ﬂow
at the entry contributes to its deposition byPULMONARY EFFECTS OF ASBESTOS 79
interception at or near the cranial edge. To the
extent that a ﬁber is entrained in the secondary
ﬂow streams that form at bifurcations, its depo-
sition probability by interception is further
enhanced.
FIBER DEPOSITION STUDIES
Sussman et al. (1991a) performed an
experimental study of ﬁber deposition within
the larger tracheobronchial airways of the
human lung using replicate hollow airway casts.
For crocidolite ﬁbers with diameters primarily
in the 0.5–0.8 µm range, interception elevated
total deposition, with the effect increasing with
ﬁber length, especially for ﬁbers >10 µmi n
length. The effect was more pronounced at
60 L/min than at 15 L/min. This is consistent
with greater axial alignment of the ﬁbers during
laminar ﬂow within the airway.
Morgan and Holmes (1984) and Morgan
et al. (1980) exposed rats for several hours by
inhalation (nose only) to glass ﬁbers 1.5 µm
in diameter and 5, 10, 30, or 60 µml o n g .
For ﬁbers longer than 10 µm, essentially all
were deposited, mostly in the head. These
data, together with the results of their earlier
studies on asbestos ﬁbers, indicate that inhala-
bility and penetrability of airborne ﬁbers into
the rat lung drops sharply with aerodynamic
diameter above 2 µm. The results by Morgan
and Holmes (1984) provide experimental ver-
iﬁcation that increasing ﬁber length enhances
lung deposition within the tracheobronchial
airways. Sussman et al. (1991b) found that the
deposition patterns of ﬁbers in the larger lung
airways were similar to those for particles of
more compact shapes. In essence, the added
deposition due to interception increased the
deposition efﬁciencies without changing the
pattern of deposition.
Most of the studies on particle deposition
patterns and efﬁciencies in hollow bronchial
airway casts of the larynx and the larger con-
ductive airways of the human bronchial tree
focused on deposition during constant ﬂow
inspirations. For studies of deposition during
cyclic inspiratory ﬂows, Gurman et al. (1984a,
1984b) used a variable-oriﬁce mechanical lar-
ynx model (Gurman et al., 1980) at the inlet
in place of the ﬁxed-oriﬁce laryngeal models
used in the prior constant-ﬂow tests. In one
series of tests, two replicate casts were con-
nected in tandem. The corresponding terminal
endings were connected with rubber tubing.
Deposition in the downstream cast was ana-
lyzed to determine the deposition pattern and
efﬁciencies during expiratory ﬂow (Schlesinger
et al.,1983). Concern about sites of enhanced
surface deposition density is stimulated by
the observation that the larger bronchial air-
way bifurcations, which are favored sites for
deposition, are also the sites most frequently
reported as primary sites for bronchial cancer
(Schlesinger and Lippmann 1978).
Deposition patterns within the nonciliated
airways distal to the terminal bronchioles may
also be quite nonuniform. Brody et al. (1981)
studied the deposition of chrysotile asbestos
in lung peripheral airways of rats exposed for
1ht o4 . 3m g /m3 of respirable chrysotile. The
animals were euthanized in groups of 3 at
0 ,5 ,a n d2 4ha n da t4a n d8da f t e rt h e
end of the exposure. The pattern of reten-
tion on the epithelial surfaces was examined
by scanning electron microscopy (SEM) of lung
sections cut to reveal terminal bronchiolar sur-
faces and adjacent airspaces. The rat does not
have recognizable respiratory bronchioles, and
the airways distal to the terminal bronchioles
are the alveolar ducts. In rats euthanized imme-
diately after exposure, asbestos ﬁbers were
rarely seen in alveolar spaces or on alveolar
duct surfaces except at alveolar duct bifurca-
tions. There were relatively high concentrations
on bifurcations nearest the terminal bronchi-
oles and lesser concentrations on more distal
duct bifurcations. In rats euthanized at 5 h, the
patterns were similar, but the concentrations
were reduced. Subsequent studies showed that
crocidolite asbestos (Roggli et al.,1987), Kevlar
aramid synthetic ﬁbers (Lee et al.,1983), and
particles of more compact shape (Brody & Roe,
1983) deposit in similar patterns, and that the
deposition patterns seen in the rat also occur
in mice, hamsters, and guinea pigs (Warheit &
Hartsky, 1990). The sudden enlargement in air
path cross section at the junction of the termi-
nal bronchiole and alveolar duct may play a
role in the relatively high deposition efﬁciency80 B. T. MOSSMAN ET AL.
at the ﬁrst alveolar duct bifurcation. Few data
are available on the ﬂow proﬁles in this region
of the lung. However, Briant (1988) demon-
strated a net axial core ﬂow in a distal direction
and a corresponding net annular ﬂow in a prox-
imal direction during steady-state cyclic ﬂow in
tracheobronchial airways, and that this might
account for such concentrated deposition on
the bifurcations of distal lung airways.
Bernstein (2007) summarized the respira-
tory and physiological parameters in rat and
human and their inﬂuence on ﬁber deposi-
tion in the lung (Table 1). It is noteworthy that
in this table, 100% deposition was assumed.
Deposition is a function of ﬁber dimension
and species. In general, it is estimated that the




The fate of ﬁbers deposited on surfaces
within the lungs depends on both the sites
of initial deposition and the physicochemical
characteristics of the ﬁbers. Thus, retained ﬁber
burden is a function of both deposition and
clearance mechanisms, which include translo-
cation, disintegration, and dissolution. Within
the ﬁrst day, most ﬁbers deposited on the tra-
cheobronchial airways are carried proximally
on the surface of the mucus to the larynx to be
swallowed and passed into the gastrointestinal
tract (GIT). For nonsmokers, the residence time
for ﬁbers on the surface of the tracheobronchial
region is too short for any signiﬁcant change
in the size or composition of the ﬁbers to take
place. For smokers, there may be bronchial air-
way surfaces that are denuded of cilia where
ﬁbers can deposit and accumulate, possibly
accounting for the greater cancer incidence in
smokers than in nonsmokers due to increased
residence times of ﬁbers in the lung. Fibers
deposited in the nonciliated airspaces beyond
the terminal bronchioles are slowly cleared
from their deposition sites by a variety of mech-
anisms and pathways. These can be classiﬁed
into two broad categories, that is, translocation
and disintegration.
Translocation
Translocation refers to the movement of the
intact ﬁber (1) along the epithelial surface to
dust foci at the respiratory bronchioles, (2) onto
the ciliated epithelium at the terminal bronchi-
oles, or (3) into and through the epithelium,
with subsequent migration to interstitial storage
sites within the lung, along lymphatic drainage
TABLE 1. Respiratory and Physiological Parameters in the Rat and Human and Their Inﬂuence on Fiber Deposition
Parameter Rat Human Rat/human ratio
Minute ventilationa (ml/min) 100 7000 0.014
Volume inhaled/6h /d (ml) 36,000 2,520,000 0.014
Lung volumea (ml) 13 4341 0.003
Alveolar surface areaa (µm2) 463,000,000,000 143,000,000,000,000 0.003
Number alveoli/lunga 40,000,000 1,000,000,000 0.04
Number alveolar cells/lunga 130,000,000 56,000,000,000 0.002
Fiber exposure concentration (f/ml) 100 0.2 500
Number ﬁbers inhaled/d 3,600,000 504,000 7
Number ﬁbers alveoli/d 0.09 0.0005 179
Number ﬁbers alveolar cell/d 0.03 0.000009 3077
Number ﬁbers/µm2 of alveolar surface/d 0.0000078 0.000000004 2206
Fiber exposure concentration (f/ml) 1,000 0.2 5,000
Number ﬁbers inhaled/d 36,000,000 504,000 71
Number ﬁbers alveoli/d 0.9 0.0005 1786
Number ﬁbers alveolar cell/d 0.28 0.000009 30,769
Number ﬁbers/µm2 of alveolar surface/d 0.000078 0.000000004 22,061
Fiber exposure concentration (f/ml) 100,000 0.2 500,000
Number ﬁbers inhaled/d 3,6000,000,000 504,000 7142
Number ﬁbers alveoli/d 90 0.0005 178,571
Number ﬁbers alveolar cell/d 28 0.000009 3,076,923
Number ﬁbers/µm2 of alveolar surface/d 0.0078 0.000000004 2,206,109
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pathways, and for very thin short ﬁbers, access
via capillary blood to distant sites, as suggested
by Monchaux et al. (1981).
Dodson et al. (1990) compared the ﬁber
contentoftissuesfromchronicallyexposedship-
yard workers, and found that while 10% of
amphiboleﬁbersinpleuralplaquesampleswere
longer than 5 µm and 8% were longer than
10 µm, the corresponding ﬁgures for chrysotile
ﬁberswere3.1and0%.Inlymphnodes,thecor-
responding ﬁgures for >10 and >5 µm lengths
were 6 and 2.5% for amphiboles and 0 and
0% for chrysotile. In lung tissue, they were 41
and 20% for amphiboles and 14 and 4% for
chrysotile. Boutin et al. (1996) showed hetero-
geneous accumulation of asbestos ﬁbers where
they occur preferentially in “black spots” of the
parietal pleura. Boutin et al. (1996) noted that
the black spots were associated with primar-
ily amphibole ﬁbers, 22.5% greater or equal
to 5 µm in length, and were in close contact
with early pleural plaques. These studies indi-
cate that ﬁber translocation is dependent on
both ﬁber diameter and ﬁber length, and that
length is one important determinant of biologi-
calresponses.Translocationmayalsooccurafter
ingestionofﬁbersbyalveolarmacrophages.Holt
(1982) proposed that ﬁbers phagocytosed by
alveolar macrophages are carried toward the
lung periphery by passing through alveolar walls
and that some of these cells aggregate in alve-
oli near larger bronchioles and then penetrate
the bronchiolar wall. Once in the bronchiolar
lumen, ﬁbers might be cleared by mucociliary
transport.
Lentz et al. (2003) examined the dimen-
sionsofﬁbersthatmaytranslocatetotheparietal
pleura, and concluded that the critical dimen-
sions were diameter <0.4 µm and length <10
µm. Lentz et al. (2003) attributed the pleural
plaques that developed in refractory ceramic
manufacturing workers to these translocated
ﬁbers. It is unclear how inhaled ﬁbers of spe-
ciﬁc dimensions get to the pleura and whether
their dimensional properties govern direct pen-
etrationthroughthelungparenchyma,transport
viathelymphaticpathway,orothermechanisms
(Broaddus et al., 2011). This differs somewhat
from the work by Lippmann (1988), which
concludedthattheriskforhumanmesothelioma
could be indexed by the number of ﬁbers thin-
ner than 0.15 µm and longer than 5 µm.
Following a single 3-h exposure (approximately
10 mg/m3 air), Coin et al. (1992) used scan-
ning electron microscopy (SEM) to examine the
clearance of chrysotile ﬁbers through 29 d post-
exposure. Fibers were deposited initially within
1 to 2 mm of the visceral pleura in rats. These
included ﬁbers greater than 16 µm in length,
which are cleared slowly, if at all. Data showed
that the numbers of ﬁbers in these peripheral
locations increased over time due to longitudi-
nal splitting. Thus, long ﬁbers and the short thin
ﬁbers that result from the constant breakdown
ofchrysotile(seelaterdiscussion)donothaveto
move far or rapidly to reach the pleural mem-
branes. Subsequently, Bernstein et al. (2004)
examined,usingquantitativethree-dimensional
(3-D) confocal microscopy, the distribution of
Brazilian chrysotile asbestos as a function of
time throughout 12 mo following a 5-d expo-
sure. While chrysotile ﬁbers passed through the
interstitium quickly after exposure, they were
no longer present in the interstitium by 6 mo.
Disintegration
Disintegration refers to a number of pro-
cesses, including the subdivision of the ﬁbers
into shorter segments; partial dissolution of
components of the matrix, creating a more
porous ﬁber of relatively unchanged external
size; or surface etching of the ﬁbers, creating
a change in the external dimensions of the
ﬁbers and/or complete dissolution. For syn-
thetic vitreous ﬁbers (SVF), ﬁber breakup is
virtually determined by length. The breakdown
into smaller diameter ﬁbrils that is characteris-
tic of asbestos ﬁbers is seldom seen. For SVF,
the relative importance of breakage into length
segments, partial dissolution, and surface etch-
ing to the clearance of ﬁbers depends upon the
size and composition of the ﬁber.
In the inhalation study of Brody et al.
(1981) with chrysotile, examination of tis-
sues by transmission electron microscopy
(TEM) revealed that ﬁbers deposited on the
bifurcations of the alveolar ducts were taken82 B. T. MOSSMAN ET AL.
up, at least partially, by type I epithelial cells
during the 1-h inhalation exposure. In the 5-h
period after exposure, signiﬁcant amounts were
cleared from the surfaces, and there was fur-
ther uptake by both type I cells and alveolar
macrophages. Within 24 h after the expo-
sure, there was an inﬂux of macrophages to
the alveolar duct bifurcations (Warheit et al.,
1986). The observations provide a basis for
ﬁber penetration of the surface epithelium
and an explanation of the mechanisms by
which inhaled asbestos ﬁbers activate chemo-
tactic complement proteins on alveolar sur-
faces. Roggli and Brody (1984) exposed rats for
1 h to a chrysotile aerosol and showed that
ﬁber clearance was associated with sequen-
tial dimensional changes in the retained ﬁbers,
with a tendency for long, thin ﬁbers to be
retained within the interstitium of the lung
parenchyma. Roggli et al. (1987) subsequently
performed essentially the same study with a
crocidolite aerosol. For the crocidolite, there
was a progressive rise in mean ﬁber length with
increasing time postexposure, but the change
was less pronounced than that for chrysotile.
In addition, there was no marked change in
ﬁber diameter over time for crocidolite ﬁbers.
In contrast, the longitudinal splitting of the
chrysotile into ﬁbrils produced a marked reduc-
tion of diameter with time.
Accumulation of ﬁbers in distal lung air-
ways may, by itself, slow the clearance of ﬁbers
and other particles from the lung. Ferin and
Leach (1976) exposed rats by inhalation to 10,
5 ,o r1m g /m3 of UICC amosite or Canadian
chrysotile for periods ranging from 1 h to 22 d.
Exposures at 10 mg/m3 f o r1 – 3ho rf o r>11 d
at 1 mg/m3 suppressed the pulmonary clear-
ance of TiO2 particles. As more than 80% of the
UICC ﬁber aerosol is comprised of very short
ﬁbers or particles, the reduction in pulmonary
clearance of TiO2 at this exposure concentra-
tion might be explained (as described later)
by particle overload. Bellmann et al. (2001)
demonstrated that during chronic exposure to
a refractory ceramic aerosol containing both
ﬁbers and shot (more compact particles), the
clearance of the ﬁbers was retarded by the
presence of the shot.
OVERLOAD ASSOCIATED WITH HIGH
LUNG BURDEN OF FIBERS
Based upon 6-wk inhalation studies of
UICC amosite in rats, Bolton et al. (1983)
reported evidence for an overload of clear-
ance at high lung burdens (exceeding about
1500 µg/rat), in which a breakdown occurs
of the intermediate-rate clearance mechanisms
(time constants of the order of 12 d). This
hypothesis is consistent with results of other
inhalation studies in rats with asbestos (Wagner
& Skidmore, 1965), quartz (Ferin, 1972), and
diesel soot (Chan et al., 1984). Vincent et al.
(1985) modiﬁed the preceding hypothesis on
the basis of additional 1-yr-long rat inhalation
studies using amosite asbestos ﬁbers at 1 and
10 mg/m3. Data demonstrated lung burden to
scale to exposure concentration in a way that
seemed to contradict the overload hypothe-
sis stated earlier. However, the general pattern
exhibited by the results for asbestos resembles
that for rats inhaling diesel fumes, suggest-
ing that such accumulations are not speciﬁc
to ﬁbrous dust. Vincent et al. (1985) offered
a modiﬁed hypothesis that although overload
of clearance can take place at high lung bur-
dens after exposure has ceased, it is canceled
by the sustained stimulus to clearance mech-
anisms provided by the continuous challenge
of chronic exposure. The linearity of the eleva-
tion in lung burden is explained in terms of a
kinetic model involving sequestration of some
inhaled material to parts of the lung where it
is difﬁcult to clear. The particular sequestration
model favored by Vincent et al. (1985) is one in
which the longer a particle remains in the lung
without being cleared, the more likely it is that
it will be sequestrated (and therefore less likely
be cleared).
Morrow (1988) developed a general
hypothesis that dust overloading, which is typ-
iﬁed by a progressive reduction of particle
clearance from the deep lung, reﬂects a break-
down in alveolar macrophage (AM)-mediated
dust removal as a result of the loss of AM
mobility. The inability of the dust-laden AM to
translocate to the mucociliary escalator is corre-
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per alveolar macrophage in the lung. When
the volume of relatively nontoxic particles
exceeds approximately 60 µm3/AM, the over-
load effect appears to be initiated. When the
distributed particulate volume exceeds approx-
imately 600 µm3 per cell, the AM-mediated
particle clearance virtually ceases, and agglom-
erated particle-laden macrophages remain in
the alveolar region. For cytotoxic particles,
these effects occur at lower loadings.
Oberdorster et al. (1990) performed addi-
tional lung instillation and inhalation studies to
further explore the Morrow (1988) hypothe-
sis and the respective roles of both AM and
polymorphonuclear leukocytes (PMN), whose
inﬂux is indicative of a cellular inﬂammatory
response. On the basis of these studies, the
following were concluded:
1. The delivered dose rate of particles to
the lung is a determinant for the acute
inﬂammatory PMN response: The same
dose delivered over days by inhalation as
opposed to sudden instillation leads to a
low response, conceivably reﬂecting the low
release rate of phagocytosis-related inﬂam-
matory mediators (e.g., chemotactic factors)
from AM.
2. The process of phagocytosis of “nuisance”
particles by AM rather than the interstitial
access of the particles appears to initiate the
inﬂux of PMN into the alveolar space.
3. The surface area of the retained particles
correlates best with inﬂammatory param-
eters rather than the phagocytized parti-
cle numbers, mass or volume. Speciﬁcally,
(a) the surface area of the fraction of par-
ticles phagocytized by AM correlates best
with the inﬂux of PMN; (b) in contrast,
an increase in alveolar epithelial permeabil-
ity, another sign of inﬂammation, correlates
with the retained surface area of the par-
ticles in the total lung, rather than with
the surface area retained in the alveolar
space; and (c) The two inﬂammatory param-
eters “alveolar PMN inﬂux” and “alveolar
epithelial permeability” are therefore sep-
arate events triggered by different mecha-
nisms.
4. Interstitialization of particles appears to be
important for inducing interstitial inﬂamma-
tory responses, including the induction of
ﬁbrotic reactions.
5. If the interstitialized particle fraction
exceeds the particle fraction remaining in
the alveolar space, the inﬂux of PMN into
the alveolar lumen decreases, conceiv-
ably reﬂecting a reversal of chemotactic
gradients from alveolar space towards the
interstitial space.
Jones et al. (1988) extended the inhala-
tion studies to lower concentrations; rats
inhaled UICC amosite asbestos at approxi-
mately 0.1 mg/m3 (equivalent to 20 ﬁbers/ml)
for 7 h/d, 5 d/wk, for up to 18 mo. The
lung burdens were compared with the previous
results for concentrations of 1 and 10 mg/m3.
Taken together, these results showed lung bur-
dens rising pro rata with exposure concen-
tration and exposure time. This accumulation
of lung burden ﬁt a kinetic model that takes
account of the sequestration of material at loca-
tions in the lung from which it cannot be
cleared. Tran et al. (1997) found that the over-
loading of the lung by ﬁbers less than 15 µm
long and more compact particles follow the
same kinetics, and are similarly affected by
overloading. For long ﬁbers (>25 µm), the dis-
appearance was independent of length and
lung burden, implying that the clearance of
such ﬁbers occurs by dissolution and fragmen-
tation into shorter lengths.
Few inhalation experiments exist at
nonoverloading concentrations using parti-
cle and ﬁber mixtures. A recent study by
Bernstein et al. (2008) compared the clearance
of chrysotile alone to chrysolite mixed with
nonﬁbrous joint compound particles in a 5-d
biopersistence study. The aerosol exposure was
in the range of 5000 WHO ﬁbers/cm3 and
12,000 to 18,000 total ﬁbers/cm3.T h ep o w -
der exposure concentration was 1.3 mg/m3.
Across all size ranges there was approxi-
mately an order of magnitude decrease in the
mean number of each size category of ﬁbers
remaining in the lungs in the chrysotile- and
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group exposed to chrysotile alone, even though
the ﬁber aerosol exposures were similar. This
study demonstrated that at nonoverloading
exposures, the addition of nonﬁbrous particles
to an aerosol containing chrysotile asbestos
ﬁbers results in a greater rate of clearance of
ﬁbers from the lung, which is likely due to an
increase in the recruitment of macrophages in
the lung, in which the acid degrades the ﬁbers.
The increased number of macrophages was
conﬁrmed histologically, with this being the
only exposure-related ﬁnding reported.
ROLE OF FIBER RETENTION IN
BIOLOGICAL RESPONSES OF VARIOUS
ASBESTOS TYPES
Differential lung clearance between ﬁbers
of chrysotile and the more rod-like amphibole
asbestos ﬁbers was found in rats that under-
went chronic inhalation exposures (Wagner
et al., 1974). The lung ﬁber burdens of
the amphiboles rose continuously throughout
2 yr of exposure, and declined slowly in the
rats removed from exposure after 6 mo. In
contrast, the lung burdens in rats exposed
to both Quebec and Zimbabwe chrysotile
increased much more slowly during exposure,
and seemed to decline after 12 mo, even with
further exposure.
The biopersistence of chrysotile ﬁbers from
other locations was studied by Bernstein and
colleagues (2004) following inhalation expo-
sures to aerosols with large number concentra-
tions of ﬁbers >20 µm in length. For chrysotile
from the Cana Brava mine in central Brazil,
the clearance half-time of the ﬁbers >20, those
5–20, and those <5 µmi nl e n g t hw e r e1 . 3 ,
2.4, and 23 d, respectively (Bernstein et al.,
2004). For chrysotile from the Coalinga mine
in California (Calidria RG144), the clearance
half-time of the ﬁbers >20, those 5–20, and
those <5 µm in length were 7 h, 7 d, and
64 d, respectively, while for tremolite asbestos
there was no clearance from the rat lungs
over the 1-yr period of observation (Bernstein
et al., 2005a). The tremolite exposures pro-
duced lung inﬂammation, granulomas, and
lung ﬁbrosis, while the chrysotile, despite
involving a much higher long ﬁber concentra-
tion (190.5 ﬁbers/cm3 >20 µm for chrysotile
vs. 106.2 ﬁbers/cm3 >20 µm for tremolite),
did not produce any measurable response.
For textile-grade chrysotile from the Eastern
Townships of Quebec, the clearance half-time
for ﬁbers >20 µm in length was 11.4 d, which
was similar to that for glass and stone wools
previously studied (Bernstein et al, 2005b),
but a longer half-life than reported earlier in
this article for California or Brazilian chrysotile.
Data suggest differences in clearance for vari-
ous types of chrysotile.
Similar differential retention of chrysotile
versus amphibole types of asbestos was found
in humans. Churg (1994) reported on analyses
of lung tissue for 94 chrysotile asbestos min-
ers and millers from the Thetford region of
Quebec, Canada. The retained chrysotile and
exposure atmosphere contained a small per-
centage of tremolite, yet the lungs contained
more tremolite than chrysotile, and the tremo-
lite content increased rapidly with the dura-
tion of exposure. While most of the inhaled
chrysotile was rapidly cleared from the lungs,
a small fraction seemed to be retained indef-
initely. After exposure ended, there was little
or no clearance of either chrysotile or tremo-
lite from the lungs, an unexpected ﬁnding.
Albin et al. (1994) studied retention patterns in
lung tissues from 69 Swedish asbestos-cement
workers and 96 controls. Data showed that
chrysotile underwent relatively rapid removal
in human lungs, whereas amphiboles (tremo-
lite and crocidolite) displayed a slower removal
pattern. Albin et al. (1994) also noted that
(1) chrysotile retention may be dependent
on dose rate, (2) chrysotile and crocidolite
retention may be increased by smoking, and
(3) chrysotile and tremolite retention may be
enhanced by the presence of lung ﬁbrosis.
The most direct evidence for the effect
of altered dust clearance rates on the reten-
tion of inhaled ﬁbers in humans comes from
studies of the ﬁber content of the lungs of
asbestos workers in various countries. Timbrell
(1982) developed a model for ﬁber deposition
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analysis of the bivariate diameter and length
distributions found in air and lung samples col-
lected at an anthophyllite mine at Paakkila in
Finland. The length and diameter distributions
of the airborne dust at this particular mine were
exceptionally broad and historic exposures
were high. For workers with the highest expo-
sure and most severe lung ﬁbrosis (Ashcroft
et al.,1988), the ﬁber distributions in some tis-
sue segments approached those of the airborne
ﬁbers. Adjacent tissue, analyzed for extent of
ﬁbrosis, showed severe ﬁbrotic lesions. Ashcroft
et al. (1988) concluded that chronic reten-
tion was essentially equal to deposition in such
segments. In these studies, lung ﬁbrosis was
associated with increased ﬁber retention, and
ﬁber retention is clearly associated with ﬁber
length and diameter. The critical ﬁber length for
mechanical clearance from the lungs is greater
than 17 µm. as conﬁrmed in the inhalation
model published by Coin et al. (1992). More
precise descriptions of the effect of ﬁber load-
ing in the lung on the development of ﬁbrosis
need to be based on the use of the most
appropriate index of ﬁber loading.
Pundsack (1955) explained that “From a
chemical point of view chrysotile behaves in
certain aspects as if it were magnesium hydrox-
ide. This is not unexpected when one considers
that the structure generally ascribed to the min-
eral consists of fundamental layers made up
in terms of a unit cell of O6-Si4-O4(OH)2-
Mg6-OH6 planes” (p. 894). Pundsack (1955)
found that the behavior of chrysotile ﬁbers
can be understood as a magnesium hydrox-
ide layer on a silica substrate and explained
that initially at neutral pH, such as that found
in lung surfactant, “in contact with relatively
pure water the ﬁber surface dissociates partially
until equilibrium of the order of that attained
by pure magnesium hydroxide is reached.” In
an acid environment (such as might occur in
the macrophage), “It is important to note that
chrysotile reacts with strong acids to form even-
tually a hydrated silica residue. Therefore, the
particles suspended in initially acid solutions
are not chrysotile in the strict sense, but repre-
sent instead intermediate reaction products of
the acid and the ﬁber” (p. 895).
Bernstein et al. (1984) and Hammad (1984)
found evidence of substantial in vivo dissolu-
tion of glass ﬁbers. Le Bouffant et al. (1984)
used x-ray analysis on individual ﬁbers recov-
ered from lung tissue to show the exchange
of cations between the ﬁbers and tissues. For
example, the ﬁbers may lose calcium and gain
potassium.
Insight on the solubility of ﬁbers in vivo
was also obtained from in vitro solubility tests.
Grifﬁs et al. (1981) found that glass ﬁbers sus-
pended either in buffered saline or serum-like
solution at 37◦C for 60 d exhibited some sol-
ubility and that the sodium content of the
residual ﬁber was reduced. Förster (1984) used
Gamble’s saline solution for tests on samples
of 18 different SVF at temperatures of 20 and
37◦C and for exposure times ranging from
1 h to 180 d using static tests, tests with
once-daily shaking, tests with continuous shak-
ing, and tests with single ﬁbers in an open
bath. There was some solubility for all ﬁbers.
Klingholz and Steinkopf (1982, 1984) studied
dissolution of mineral wool, glass wool, rock
wool, and basalt wool at 37◦C in water and
in a Gamble’s solution modiﬁed by omission
of the organic constituents. Most of the tests
used a continuous-ﬂow system in which the
pH was 7.5–8. There was relatively little dis-
solution in distilled water in comparison to that
produced by the modiﬁed Gamble’s solution.
The surfaces developed a gel layer that, for the
smaller diameters, extended throughout the
ﬁber cross section. Thus, ﬁbers may become
both smaller in outline and more plastic to
deformation.
Scholze and Conradt (1987) performed a
comparative in vitro study of the chemical
durability of SVF in a simulated extracellu-
lar ﬂuid under ﬂow conditions. Seven vitre-
ous, three refractory, and three natural ﬁbers
were involved. Samples of the leachate were
analyzed, and the silicon concentrations were
used to roughly classify the ﬁbers according
to their chemical durability in terms of glass
network dissolution. A durability ranking of
ﬁber materials was expressed in terms of a
characteristic time required for the complete
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SVF exhibited relatively poor durability (with
network dissolution velocities ranging from 3.5
to 0.2 nm/d for a glass wool and an E-glass
ﬁber, respectively), whereas natural mineral
ﬁbers were persistent against the attack of the
biological ﬂuid (e.g., less than 0.01 nm/df o r
crocidolite).
Davies et al. (1984) exposed rats to SVF
aerosols at 10 mg/m3 for 7 h/d, 5 d/wk for
1 yr as compared to the single exposure of
several hours duration used by Morgan and
Holmes (1984). The percentage of glass ﬁbers
with diameters less than 0.3 µm recovered
from the lungs was consistently less than that
in the original ﬁber suspension, and the reduc-
tion was more marked in the animals that were
sacriﬁced following a period of recovery from
the exposures than from those sacriﬁced at the
end of the exposure. The degree of ﬁber etch-
ing increased with residence times in the lungs.
Glass wool with and without resin was also
etched, but to a lesser extent, and the etching
of the rock wool ﬁbers was considerably less.
In a study of dissolution of inhaled ﬁbers by
Eastes and Hadley (1995), rats were exposed
for 5 d to 4 types of airborne, respirable-sized
SVF and to crocidolite ﬁbers. The SVF included
2 glass wools, and 1 each of rock and slag wool.
After exposure, animals were sacriﬁced at inter-
vals up to 18 mo, and the numbers, lengths,
and diameters of a representative sample of
ﬁbers in their lungs were measured. Long ﬁbers
(>20 µm) were eliminated from rat lungs at a
rate predicted from the dissolution rate mea-
sured in vitro. The long SVF were nearly com-
pletely eliminated in several months, whereas
most long crocidolite asbestos ﬁbers remained
at the end of the study. The number, length,
and diameter distributions of ﬁbers remaining
in the rat lungs agreed well with a computer
simulation of ﬁber clearance that assumed that
the long ﬁbers dissolved at the rate measured
for each ﬁber in vitro, and that the short ﬁbers
of every type were removed at the same rate
as short crocidolite asbestos. Thus, long SVF
were cleared by complete dissolution at the
rate measured in vitro, and short ﬁbers did
not dissolve and were cleared by macrophage-
mediated physical removal.
In an inhalation study using 9 ﬁber types,
Bernstein et al. (1996) exposed rats to an
aerosol (mean diameter of ∼1 µm) at a con-
centration of 30 mg/m3,6h /day for 5 d with
post-exposure sacriﬁces at 1 h, 1 day, 5 d,
4 wk, 13 wk, and 26 wk. At 1 h following
the last exposure, the 9 types of ﬁbers were
found to have lung burdens ranging from 7.4
to 33 × 106 ﬁbers/lung with geometric mean
diameters (GMD) of 0.40–0.54 µm, reﬂect-
ing the different bivariate distributions in the
exposure aerosols. The ﬁbers cleared from the
lungs following exposure with weighted half-
lives ranging from 11 to 54 d. The clearance
was found to closely reﬂect the clearance of
ﬁbers in the 5–20 µm length range. An impor-
tant difference in removal was seen between
the long ﬁber (L > 20 µm) and shorter ﬁber
(L between 5 and 20 µma n dL< 5 µm)
fractions, depending upon composition. For all
glass wools and the stone wools, the longer
ﬁbers were removed faster than the shorter
ﬁbers. It was found that the time for complete
ﬁber dissolution based on the acellular in vitro
dissolution rate at pH 7.4 was signiﬁcantly cor-
related with the clearance half-times of ﬁbers
>20 µm in length. No such correlations were
noted with any of the length fractions using
the acellular in vitro dissolution rate at pH 4.5.
Examination of the ﬁber length distribution and
particles in the lung from 1 h through 5 d of
exposure indicated that, especially for those
ﬁbers that form leached layers, ﬁber breakage
may have occurred during this early period.
These results demonstrate that for ﬁbers with
high acellular solubility at pH 7.4, the clearance
of long ﬁbers is rapid.
Eastes and Hadley (1996) ﬁtted much of
the data just cited into a mathematical model of
ﬁber carcinogenicity and ﬁbrosis. Their model
predicts the incidence of tumors and ﬁbrosis
in rats exposed to various types of rapidly dis-
solving ﬁbers in an inhalation study or in an
intraperitoneal (ip) injection experiment. This
takes into account the ﬁber diameter and the
dissolution rate of ﬁbers longer than 20 µmi n
the lung, and predicts the measured tumor and
ﬁbrosis incidence to within approximately the
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concept for the model is that a rapidly dis-
solving long ﬁber has the same response in an
animal bioassay as a smaller dose of a durable
ﬁber. Long, durable ﬁbers have special signiﬁ-
cance, since there is no effective mechanism by
which these ﬁbers may be removed. In particu-
lar, the postulation is that the effective dose of a
dissolving long ﬁber scales as the residence time
of that ﬁber in the extracellular ﬂuid. The resi-
dence time of a ﬁber is estimated directly from
the average ﬁber diameter, density, and the
ﬁber dissolution rate as measured in simulated
lung ﬂuid at neutral pH.
The incidence of ﬁbrosis in chronic inhala-
tion tests, the observed lung tumor rates, and
the incidence of mesothelioma in the ip model
were all well predicted by this model. The
model allows one to predict, for an inhala-
tion or ip experiment, what residence time
and dissolution rate are required for an accept-
ably small tumorigenic or ﬁbrotic response to a
given ﬁber dose. For an inhalation test in rats at
the maximum tolerated dose (MTD), the model
suggests that less than 10% incidence of ﬁbrosis
would be obtained at the maximum tolerated
dose of 1-µm diameter ﬁbers if the dissolu-
tion rate were greater than 80 ng/cm2/h. The
dissolution rate that would give no detectable
lung tumors in such an inhalation test in rats
is much smaller. Thus, a ﬁber with a disso-
lution rate of 100 ng/cm2/h has a nonsignif-
icant chance of producing either ﬁbrosis or
tumors by inhalation in rats, even at the MTD.
This model provides manufacturers of SVF and
other synthesized ﬁbers with design criteria for
ﬁbrous products that minimize, if not elimi-
nate, the potential for producing adverse health
effects. Support for the use of biopersistence
data for the prediction of ﬁbrosis and tumor
responses in rats from both ip injection stud-
ies and chronic inhalation studies for ﬁbers >5
and >20 µm in length was also provided by
Bernstein et al. (2001a, 2001b). For the inhala-
tion studies, Bernstein et al. (2001a, 2001b)
used collagen deposition at the bronchoalveo-
lar junction as a predictor of interstitial ﬁbrosis.
Fibrosis was also associated with the develop-
ment of lung cancers in rats (Davis & Cowie,
1990). The consensus from these and other
studies already mentioned suggests that some
SVF, including ceramic ﬁbers, are more durable
than others and are less persistent than croci-
dolite asbestos in the lung.
As discussed earlier, the retention, dose,
dimensions, durability, and composition of
amphibole asbestos ﬁbers, in contrast to dis-
integration and/or dissolution of SVF, are
critical parameters related to adverse health
effects occurrence, with chrysotile asbestos
ﬁbers falling between these two extremes.
The initial database of well-conducted inhala-
tion toxicology studies from which these con-
cepts are based included primarily studies of
SVF, many of which included asbestos-exposed
groups as positive controls. More recently, stud-
ies on different types of asbestos ﬁbers have
extended these concepts, differentiating ser-
pentine (chrysotile) asbestos from amphibole
asbestos. The existing database of ﬁber tox-
icity studies indicates that human exposure
to respirable ﬁbers that are biopersistent in
the lung also induces signiﬁcant and persistent
pulmonary inﬂammation, cell proliferation, or
ﬁbrosis, and therefore needs to be viewed with
concern.
FACTORS THAT INDUCE FIBER
TOXICITY
Mineral ﬁber toxicology has been associ-
ated with three key factors: dose, dimension,
and durability. Particle surface activity is also
likely to play some role, but at this point
in time, its role remains to be established.
The dose of ﬁbers is determined by physical
characteristics/dimensions and exposure lev-
els, which are also affected by how the ﬁbrous
material is used and the control procedures
that are implemented. Most asbestos ﬁbers are
thinner than SVF in commercial insulation and
other products.
Fiber dimensions are important because
only very thin ﬁbers are respirable and pene-
trate into the deep alveolar region of the lung,
and because ﬁber length may impact their tox-
icity. As emphasized earlier, short ﬁbers of the
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will be cleared by mechanisms similar to those
for nonﬁbrous particles. These mechanisms
include mucociliary clearance and macrophage
phagocytosis, as well as clearance through the
lymphatics. It is generally concluded that only
the long ﬁbers that the macrophage cannot fully
engulf and that are biopersistent lead to dis-
ease (HEI, 1991; IOM, 2008). However, a role
for short ﬁbers in disease cannot be completely
ruled out.
This leads to the third factor involved in
ﬁber toxicity, which is persistence, a func-
tion of ﬁber durability and pathogenicity.
Those ﬁbers whose chemical composition ren-
ders them wholly or partially soluble once
deposited in the lung are likely to either dis-
solve completely or dissolve until they are
sufﬁciently weakened focally to undergo break-
age into shorter ﬁbers. The remaining short
ﬁbers can then be removed from the deep lung
though macrophage phagocytosis and mucocil-
iary clearance.
SVF, such as glass wool, slag wool, and
rock wool, are amorphous structures. In the
lung, these ﬁbers were found to dissolve by
two principal mechanisms, either through con-
gruent or incongruent dissolution. Congruent
dissolution of SVF leads to products that are
completely soluble in the aqueous phase. In
contrast, incongruent dissolution leads to one
or more insoluble products.
The importance of ﬁber length in asbestos
toxicity and disease was ﬁrst addressed in
studies by Vorwald et al. (1951) in exper-
imental models of asbestosis. Subsequently,
dose, dimension, and durability were shown
to be important determinants of toxicity for
SVF or asbestos (Bernstein et al. 2001a; 2001b;
Hesterberg et al. 1998a;1998b; Miller et al.
1999; Oberdorster 2000; Stanton et al. 1981;
reviewed in Case et al. 2011). The importance
of durability in differentiating asbestos ﬁber
toxicity between the serpentine mineral ﬁber,
chrysotile, and the amphibole mineral ﬁbers,
such as amosite and crocidolite, was addressed
more recently (Bernstein & Hoskins, 2006).
Because ﬁbers tend to align with the airﬂow
into in the airways when inhaled into the lung,
the ﬁber diameter is the primary determinant
of deposition in the lung. A ﬁber is unique
among inhaled particles in that the ﬁbers aero-
dynamic diameter is largely related to threefold
greater than ﬁber diameter. Because of this,
long thin ﬁbers penetrate into the deep lung.
Within the lung, ﬁbers that are fully engulfed by
the macrophage are removed as with any other
particle. However, those ﬁbers that are too long
to be fully engulfed by the macrophage can-
not be cleared by this route. Zeidler-Erdely
et al. (2006) showed that 20-µmﬁ b e r sa r e
fully engulfed by human alveolar macrophages.
Alveolar macrophages are smaller in the rat,
and thus the critical length is proportionately
shorter. Longer ﬁbers remain in the lung and
are cleared from the lung only if they dissolve
or break apart.
Extensive work on modeling the dissolution
of mineral ﬁbers using in vitro dissolution tech-
niques and inhalation biopersistence demon-
strated that lung has a large buffer capacity
(Mattson, 1994) These studies showed that an
equivalent in vitro ﬂow rate of up to 1 ml/min
is required to provide the same dissolution rate
of SVF that occurs in the lung. This large ﬂuid
ﬂow within the lung results in the disassociation
of the soluble components in the ﬁbers. The
association of longer ﬁbers (20–50 µm) with
lung disease as opposed to shorter ﬁbers (3 µm
or less) was reported by Vorwald et al. (1951),
who concluded that “the mode of action of
the long asbestos ﬁber in the production of
asbestosis is primarily mechanical rather than
chemical in nature” and that “long asbestos
ﬁbers are essential in the production of the
ﬁbrosis; short ﬁbers are incapable of producing
this reaction” (Vorwald et al., 1951). The rela-
tionship between chemical composition and
dissolution and subsequent breakage was ﬁrst
reported by Hammad (1984). SVF <5 µmi n
length had the longest retention in the lung fol-
lowing short-term inhalation, with longer ﬁbers
clearing more rapidly and ﬁbers >30 µmi n
length clearing very rapidly. Hammad (1984)
proposed that clearance of mineral wools is a
result of biological clearance and the elimina-
tion of ﬁbers by dissolution and subsequent
breakage. Data also suggested that the long
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ﬁbers, which explained the rapid disappear-
ance of these ﬁbers from the lung. The shorter
ﬁbers appeared to have a longer retention time
because ﬁbers were added to the pool by
breakage of longer ﬁbers.
CAVEATS OF CHRONIC INHALATION
STUDIES USING FIBERS
Early chronic inhalation studies of ﬁbers in
the rat were often performed without consid-
eration of the respirability of the ﬁbers and
without determining the length distribution of
the ﬁbers. In addition, studies were often per-
formed at high total particle/ﬁber exposure
concentrations. As mineral ﬁbers often occur
in bundles of long strands, investigators would
grind the ﬁbers to produce a more respirable
fraction instead of separating the ﬁbers from
the bundles. This process frequently pulver-
ized the long respirable ﬁber fraction, pro-
ducing excessive particles and shorter ﬁbers
sufﬁcient to produce lung overload in rats.
High concentrations of insoluble dusts when
administered by inhalation in the rat were
found to overload the lung by compromis-
ing the clearance mechanisms, which resulted
in inﬂammation and a tumorigenic response
(Bolton et al., 1983; Morrow, 1988; Muhle
et al., 1988; Oberdorster, 1995a, 1995b).
Historically, inhalation toxicology studies were
performed far above the ﬁber concentration
levels to which humans might be exposed.
When the exposure level is elevated 100,000-
fold higher than human exposures, as occurred
in most of the earlier ﬁber inhalation studies
with chrysotile and amphibole asbestos, lung
overload occurs.
While many chronic inhalation toxicology
studies of different types of ﬁbers were per-
formed, their design and subsequent interpre-
tation are often confounded by the ﬁber size
distribution and the ratio of longer ﬁbers to
shorter ﬁbers, as well as inclusion of nonﬁ-
brous particles. In many of these investigations
the exposures often approach or exceed that
which has been shown to produce “lung over-
load” in the rat. Thus, it may become difﬁcult
to compare the effects observed in one study
with those of another. In most chronic inhala-
tion studies on asbestos, the ﬁber exposure
concentration was determined based upon a
gravimetric concentration of 10 mg/m3 without
regard for ﬁber number or size. High concen-
trations of insoluble dusts, when administered
by inhalation in the rat, were found to (1) over-
load the lung by compromising the clearance
mechanisms; (2) result in inﬂammation; and
(3) result in a nonspeciﬁc tumorigenic response
(Bolton et al., 1983; Morrow, 1988; Muhle
et al., 1988; Oberdorster, 1995a, 1995b).
The issue of using equivalent ﬁber num-
bers for exposure was approached in a
study reported by Davis et al. (1978) where
chrysotile, crocidolite, and amosite were com-
pared on an equal mass and equal number
basis. However, the ﬁber number was deter-
mined by phase-contrast optical microscopy
(PCOM) and thus the actual ﬁber number,
especially of the chrysotile ﬁbers, was proba-
bly greatly underestimated. As an example, by
PCOM, the 10-mg/m3 exposure to chrysotile
by PCOM was approximately 2000 f/cm3 with
length greater than 5 µm, while a similar
mass concentration of another chrysotile sam-
ple measured by SEM was 10,000 f/cm3 with
length greater than 5 µm. In contrast, Mast
et al. (1995) reported for 10 mg/m3 a total ﬁber
count of 100,000 f/cm3 as measured by SEM.
Another problem in interpretation of results is
the little quantitative data presented in these
publications on nonﬁbrous particle concentra-
tions in the exposures. Pinkerton et al. (1983)
presented summary tables of length measure-
ments of Calidria chrysotile by SEM in which
the number of nonﬁbrous particles counted is
stated. The aerosol exposure concentration of
nonﬁbrous particles cannot be extracted from
the data presented. In all studies, the asbestos
was ground prior to aerosolization, a procedure
that produces a lot of short ﬁbers and nonﬁ-
brous dust. Most of the studies prior to Mast
et al. (1995) used an apparatus (Wright Dust
Feed) for aerosolizing ﬁbers that employed a
rotating steel blade to push/chop the ﬁbers off
a compressed plug and into the airstream. As
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asbestos and the ﬂow through the apparatus
often abraded the steel surfaces, resulting in
considerable exposure to the metal fragments
as well. These factors contribute signiﬁcantly to
the difﬁculty in interpreting the results of these
earlier chrysotile and amphibole inhalation
exposure studies. These discrepancies in study
design also bring into question the difﬁculties in
comparative analysis of various types of ﬁbers.
As an example, in the chronic inhalation study
of refractory ceramic ﬁbers (RCF1) reported by
Mast et al. (1994), the exposure aerosol had
a total average of 234 ﬁbers/cm3 of which
there were approximately 100 ﬁbers/cm3 with
L > 20 µm. This resulted in a total ﬁber number
in the lung after 24 mo of exposure of approx-
imately 1 million ﬁbers. In the chrysotile study
reported by Hesterberg et al. (1999), the expo-
sure aerosol had a total average of 102,000
ﬁbers/cm3 (the number of ﬁbers/cm3 longer
than 20 µm was not reported). This resulted
in a total ﬁber number in the lung after 24
mo of exposure of approximately 55 million
ﬁbers.
In 1988, a series of chronic inhalation
studies on SVF was performed that took into
account the respirability of ﬁbers in rats and
the importance of ﬁber length in both the
preparation of the ﬁbers and the exposure
techniques (Hesterberg et al. 1992, 1995; Mast
et al., 1995; McConnell et al., 1995). The
results of these studies indicated that the more
soluble ﬁbers that were tested showed little
or no pathogenic response, while less solu-
ble ﬁbers demonstrated more response. To
further investigate this, a 5-d inhalation pro-
tocol was developed for the evaluation of
the biopersistence of SVF (Bernstein et al.,
1994; Musselman et al., 1994), with numerous
ﬁbers analyzed using this protocol (Bernstein
et al., 1996; Hesterberg et al., 1998a). This
5-d inhalation exposure was proposed by the
U.S. Environmental Protection Agency for eval-
uating the pathological response and biopersis-
tence of inhaled ﬁbers. The biopersistence pro-
tocol was also incorporated by the European
Commission (Bernstein & Riego-Sintes, 1999)
as part of the European Commission’s synthetic
ﬁber directive (EUR, 1997). Subsequently,
McConnell et al. (1999) reported on a multiple-
dose study on amosite asbestos in which
particle and ﬁber number and length were
comparable to the SVF exposure groups. In this
hamster inhalation study, the amosite aerosol
concentrations ranged from 10 to 69 f/cm3
for ﬁbers longer than 20 µma n dw e r ec h o -
sen based upon a previous, multidose 90-d
subchronic inhalation study (Hesterberg et al.,
1999). In the chronic study, only high-dose
amosite asbestos exposure resulted in mesothe-
liomas (19.5%). In a short-term exposure study
in the rat (6 h/d, 5 d) using tremolite asbestos
at a long ﬁber exposure concentration of
100 f/cm2 for ﬁbers longer than 20 µm, inter-
stitial ﬁbrosis developed within 28 d after ces-
sation of the 5-d exposure (Bernstein et al.,
2005a). No chronic inhalation studies using
chrysotile asbestos with ﬁber selection tech-




The European Commission (Bernstein &
Riego-Sintes, 1999) as part of the European
Commission’s synthetic ﬁber directive (EUR,
1997), also stated that current short-term test-
ing methods, deﬁned as 3 mo or less in
exposure duration, evaluate a number of end-
points that are considered relevant for lung
diseases induced by ﬁbers, such as asbestos.
Subchronic studies that assessed biomarkers of
lung injury including persistent inﬂammation,
cell proliferation, and ﬁbrosis, were consid-
ered to be more predictive of carcinogenic
potential than in vitro measures of cellular
toxicity. Of particular importance in the eval-
uation of ﬁber toxicity using the 90-d sub-
chronic inhalation toxicity study is the ﬁnding
that “All ﬁbers that have caused cancer in
animals via inhalation have also caused ﬁbro-
sis, and at an earlier time point, that is, by
3 months. However, there have been ﬁber
exposures that have caused ﬁbrosis but not
cancer. Therefore, in vivo studies that involve
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subsequent assessment of relevant endpoints,
notably ﬁbrosis, are probably adequately con-
servative for predicting long-term pathology -
that is, will identify ﬁbers that have a ﬁbrogenic
or carcinogenic potential” (p. 518). The work-
ing group also recommended that speciﬁc
parameters need to be measured in 90-d ﬁber
inhalation studies (EUR, 1997), parameters that
were noted in the U.S. EPA Guideline for
Combined Chronic Toxicity/Carcinogenicity
Testing of Respirable Fibrous Particles (U.S. EPA,
2001). These parameters need to include lung
weight, ﬁber lung burden and clearance, cell
proliferation, inﬂammatory response markers,
and histopathology. The European Commission
guideline for subchronic inhalation toxicity test-
ing of synthetic vitreous ﬁbers in rats (Bernstein
& Riego-Sintes, 1999) and the ILSI Panel (ILSI,
2000) specify similar parameters.
Bellmann et al. (2003) reported on a cal-
ibration study to evaluate the endpoints in a
90-d subchronic inhalation toxicity study fol-
lowingthisprotocolofman-madevitreousﬁbers
with a range of biopersistence and of amosite
asbestos. One of the ﬁbers was a calcium–
magnesium–silicate (CMS) ﬁber for which the
stock preparation had a large concentration of
nonﬁbrous particulate material in addition to
the ﬁbers. After chronic inhalation of the ﬁber
X607, a CMS ﬁber that had considerably fewer
particles present, no lung tumors or ﬁbrosis
were detected (Hesterberg et al., 1998b). In the
Bellmann et al. (2003) 90-d study, due to the
method of preparation the mean aerosol expo-
sure concentration for the CMS ﬁber was 286
ﬁbers/cm3 with length <5 µm, 990 ﬁbers/cm3
with length >5 µm, and 1793 particles/cm3,
a length distribution that is not observed in
manufacturing environments. The total mean
CMS exposure concentration was 3,069 par-
ticles and ﬁbers/cm3. Evidence indicated that
“the particle fraction of CMS that had the same
chemical composition as the ﬁbrous fraction
seemed to cause signiﬁcant effects” (p. 1172).
For the CMS ﬁber, results showed that the num-
ber of polymorphonuclear leukocytes (PMN)
in the bronchoalveolar lavage ﬂuid (BALF) was
higher and interstitial ﬁbrosis was more pro-
nounced than had been expected on the basis
ofbiopersistencedata.Inaddition,theinterstitial
ﬁbrosis persisted through 14 wk after cessation
of the 90-d exposure. This effect attributed to
particles was observed with an exposure con-
centration of 3,069 particles and ﬁbers/cm3,
of which 50% were nonﬁbrous particles or
shortﬁbers.Amarkedlymorepronouncedeffect
would be expected to occur at higher exposure
concentrations.
Bernstein et al. (2006) reported on the tox-
icological response of the commercial Brazilian
chrysotile following exposure in a multidose
subchronic 90-d inhalation toxicity study that
was performed according to the protocols men-
tionedaboveasspeciﬁedbytheU.S.EPA(2001)
and Bernstein and Riego-Sintes (1999). In this
study, Wistar male rats were exposed to 2
chrysotile ﬁber levels at mean ﬁber aerosol con-
centrations of 76 ﬁbers with L > 20 µm/cm3
(3413 total ﬁber/cm3; 536 WHO ﬁber/cm3)
or 207 ﬁbers with L > 20 µm/cm3 (8941
totalﬁber/cm3;1429WHOﬁber/cm3).Animals
were exposed using a ﬂow-past, nose-only
exposure system for 5 d/wk, 6 h/d, during
13 consecutive weeks, followed by a subse-
quent nonexposure period lasting for 92 d.
Animals were sacriﬁced after cessation of expo-
sure, and after 50 and 92 d of nonexposure
recovery. At each sacriﬁce, subgroups of rats
were assessed for the determination of the
lung burden; histopathological examination;
cell proliferation response; contents of bron-
choalveolar lavage, with the determination of
inﬂammatory cells; clinical biochemistry; and
for analysis by confocal microscopy. Exposure
to chrysotile for 90 d and 92 d of recovery,
at a mean exposure of 76 ﬁbers/cm3 with
L > 20 µm (3413 total ﬁber/cm3), resulted
in no apparent ﬁbrosis (Wagner score 1.8 to
2.6) at any time point. The long chrysotile ﬁbers
were observed to break apart into small par-
ticles and smaller ﬁbers. At a mean exposure
concentration of 207 ﬁbers/cm3 with L > 20
µm (8941 total mean ﬁbers/cm3) slight ﬁbrosis
wasobserved.Incomparisonwithotherstudies,
chrysotile produced less inﬂammatory response
thanthebiosolublesyntheticvitreousﬁberCMS
referred to earlier, and considerably less than
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exposure to a commercial chrysotile product in
a subchronic 90-d inhalation toxicology (total
mean ﬁber concentrations as measured by TEM
were 3413 ﬁbers/cm3 air and 8941 ﬁbers/cm3
air), no adverse lung pathology was observed
at the lower exposure level, and only a slight
ﬁbrotic response was seen at the higher expo-
sure level in rodents (Bernstein et al., 2006).
In contrast, tremolite (an amphibole asbestos)
exposure for 5 d (6 h/d) at a mean aerosol con-
centration (per cubic centimeter) of 100 ﬁbers
with L > 20 µm (2016 total ﬁber/cm3) resulted
inextensiveinﬂammatoryresponsewithintersti-
tial ﬁbrosis observed within 28 d after cessation
of exposure (Bernstein et al., 2005a).
In a recent study by Bernstein et al (2010),
the translocation and pathological response of
a commercial chrysotile product similar to that
which was used through the mid 1970s in
a joint compound intended for sealing the
interface between adjacent wall boards was
evaluated in comparison to amosite asbestos.
This study was unique in that it presented a
combined real-world exposure and was the
ﬁrst study to investigate whether there were
differences between chrysotile and amosite
asbestos ﬁbers in time course, size distribution,
and pathological response in the pleural cav-
ity. Rats were exposed by inhalation 6 h/df o r
5 d to either sanded joint compound consist-
ing of both chrysotile ﬁbers and sanded joint
compound particles (CSP) or amosite asbestos.
The mean number of ﬁbers longer than
20 µm was 295 ﬁbers/cm3 for chrysotile and
201 ﬁbers/cm3 for amosite. The mean num-
ber of WHO ﬁbers (deﬁned as ﬁbers >5 µm
long, <3 µm wide, and with length:width
ratios > 3:1) in the CSP atmosphere was
1496 ﬁbers/cm3, which was more than 10,000
times the OSHA occupational exposure limit of
0.1 ﬁbers/cm3. The amosite exposure atmo-
sphere had fewer shorter ﬁbers, resulting in a
mean of 584 WHO ﬁbers/cm3. The use of
both confocal microscopy and SEM enabled
the identiﬁcation of ﬁbers as well as possible
inﬂammatory responses in the lung, visceral
pleura, and parietal pleura. Subgroups were
examined over time through 1 yr postexposure.
No pathological responses were observed at
any time point in the CSP exposure group.
The long chrysotile ﬁbers (L > 20 µm) cleared
rapidly (T1/2 of 4.5 d) and were not observed
in the pleural cavity. In contrast, a rapid inﬂam-
matory response occurred in the lung following
exposure to amosite, resulting in Wagner grade
4 interstitial ﬁbrosis within 28 d. Long amosite
ﬁbers had a T1/2 > 1000 d in the lung and
were observed in the pleural cavity within
7 d postexposure. By 90 d the long amosite
ﬁbers were associated with a marked inﬂam-
matory response on the parietal pleura. This
study shows that relevant inhalation exposure
to chrysotile ﬁbers and joint compound parti-
cles, in contrast to amosite asbestos, does not
initiate an inﬂammatory response in the lung.
Moreover, the chrysotile ﬁbers did not migrate
to, or induce an inﬂammatory response in, the
pleural cavity.
Molecular and proliferative changes
important in carcinogenicity were examined
in epithelial and mesothelial cells at high
(8.2 mg/m3) and lower (0.17 mg/m3) average
gravimetric concentrations of NIEHS reference
samples of chrysotile or crocidolite asbestos.
Rat lungs were evaluated at 5 and 20 d after
initial exposures to asbestos and at 20 d post
cessation of a 20-d exposure (BeruBe et al.,
1996; Quinlan et al., 1994, 1995) (Table 2). In
both mesothelial and epithelial cells, increases
in cell proliferation, as measured by incor-
poration of 5-bromodeoxyuridine (5’BrdU)
using histochemistry, were observed at only the
high dose in response to both asbestos types
at 5 d. These rises persisted with exposures
to crocidolite for 20 d in mesothelial cells.
Fibrotic lesions and elevations in hydrox-
yproline, a biochemical marker of collagen
synthesis, were seen only at high crocidolite
exposures for 20 d, but appeared in both
asbestos groups after an additional 20 d
without ﬁber exposure. Signiﬁcant elevation
in mRNA levels of c-jun protooncogene and
ornithine decarboxylase (odc), an enzyme
necessary for cell proliferation and linked to
tumor promotion, were observed exclusively
at high concentrations of crocidolite asbestos
in lung homogenates. Data suggested that
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TABLE 2. Molecular and Phenotypic Markers Measured in Subchronic Rat Inhalation Studies
Using Asbestos
Crocidolite Chrysotile
High∗ Low High Low
Endpoints 8.25∗ {2800} 0.16 {60} 8.23 {2457} 0.18 {32}
5’BrdU (proliferation)
Bronchial epithelial cells >(5 d) N.D. >(5 d) –
Mesothelial cells >(20 d) N.D. >(5 d) –
c-jun Oncogene > –– –
odc (Ornithine decarboxylase) > –– –
Hydroxyproline (ﬁbrosis) >(20 d) – − (20 d) –
Note. Modiﬁed from Shukla, Vacek, and Mossman (2004b).Asterisk indicates time-weighted
average concentration (mg/m3 air). { } = Average number of ﬁbers >5 µm/cc air (PCOM). N.D.,
not done. ( ) = Time of observed change. Endpoints of cell proliferation including incorporation
of 5’BrdU in individual cells by histochemistry, mRNA levels of the early response protoonco-
gene, c-jun, and odc, a marker of tumor promotion, and hydroxyproline levels, a marker of
increased collagen production, in lung homogenates, were measured after 5 and 20 d of exposure
to asbestos types at 2 concentrations.
and biochemical markers of disease may be
promising in deﬁning dose-related asbestos





ﬁbers shorter than 20 µmi nl e n g t h ,a n de v e n
morethatarelessthan5µminlength.Becauseof
the mechanical processes in breaking the ﬁbers,
ﬁber length usually follows a lognormal distri-
bution. The clearance of the shorter ﬁbers in
biopersistence studies was shown to be either
similar to or faster than the clearance of insolu-
ble nuisance dusts (Muhle et al., 1987; Stöber
et al., 1970). A report issued by the Agency for
Toxic Substances and Disease Registry (ATSDR)
was entitled “Expert Panel on Health Effects
of Asbestos and Synthetic Vitreous Fibers: The
Inﬂuence of Fiber Length.” In this report, the
experts stated, “Given ﬁndings from epidemio-
logicstudies,laboratoryandanimalstudies,and
in vitro genotoxicity studies, combined with the
lung’s ability to clear short ﬁbers, that there is
a strong weight of evidence that asbestos and
SVFs shorter than 5 µm are unlikely to cause
cancer in humans” (ATSDR, 2003; U.S. EPA,
2003). However, this panel did not evaluate the
role of short ﬁbers in noncarcinogenic health
effects in humans.
In the series of SVF chronic inhalation stud-
ies performed at the Research and Consulting
Company Ltd., in the 1990s, the relation-
ship between exposure to more durable ﬁbers
and lung disease also became apparent and
resulted in the design of the inhalation bioper-
sistence study as already described. The impor-
tance of ﬁber length to the potential of a ﬁber
to produce a pathogenic effect is well docu-
mented in a number of studies (Goodglick &
Kane, 1990; Lippmann, 1990; McClellan et al.,
1992; WHO, 1988).
To evaluate the inﬂuence of ﬁber length
on clearance, Bernstein et al. (1996) exam-
ined the biopersistence of 9 different ﬁbers
types using this inhalation biopersistence pro-
tocol determining the clearance of ﬁbers in
3 length categories: ﬁbers with length <5 µm,
5–20 µm, and >20 µm. The length cate-
gories were selected based upon lung physio-
logical response. Fibers <5 µmi nl e n g t hc a n
be completely phagocytized by macrophages
and treated by the lung essentially as nonﬁ-
brous particles. The length fraction >20 µm
was considered as greater than the size of the
macrophage, and represented a ﬁber length
that the macrophage most likely could not
fully phagocytize. It was pointed out that these
length fractions were not considered as strict
cutoffs, but rather representative of mecha-
nistic categories with the transition between
categories thought to occur over a range of94 B. T. MOSSMAN ET AL.
lengths. The ﬁber clearance half-times in each
of these length fractions were then examined
for association with the ﬁber durability, which
was determined using an acellular in vitro
ﬂow-though system using a modiﬁed Gamble’s
solution. This analysis provides a reliable indi-
cation that the disappearance of ﬁbers longer
than 20 µm may be mediated by their disso-
lution at pH 7.4. While not reported in the
publication, Bernstein (personal communica-
tion) chose the 20-µm cutoff for the longer
ﬁbers by performing iterative analyses starting
at a ﬁber length of 10 µm and greater and
then increasing the minimum ﬁber length to
determine at what lower cutoff the best correla-
tion of half-time was obtained with the in vitro
durability date. It was found that the best asso-
ciation between in vitro dissolution and lung
clearance in the rat was at approximately 18
to 20 µm. At ﬁber lengths >20 µm, this cor-
relation diminished as a result of fewer and
fewer ﬁbers being available in the longer size
ranges.
Subsequently, in an analysis that pro-
vided the basis for the European Commission’s
Directive on synthetic vitreous ﬁbers, Bernstein
et al. (2001a, 2001b) reported on the correla-
tion between the biopersistence of ﬁbers longer
than 20 µm and the pathological effects fol-
lowing either chronic inhalation or ip injection
studies. This analysis showed that it was possi-
ble, using the clearance half-time of the ﬁbers
longer than 20 µm as obtained from the inhala-
tion biopersistence studies, to predict the num-
ber of ﬁbers longer than 20 µm remaining
following a 24-mo chronic inhalation exposure;
the early ﬁbrotic response (collagen deposi-
tion) observed after 24 mo of exposure in the
chronic inhalation toxicology studies; and the
number of tumors and ﬁber dose in the chronic
ip injection studies. These studies, however,
only include SVF.
For mineral ﬁbers, the clearance half-time
of ﬁbers longer than 20 µmr a n g e sf r o maf e w
days to less than 100 d. This is illustrated in
Table 3. In this table the results are also shown
from biopersistence studies performed on ser-
pentine (chrysotile) and amphibole asbestos
using the same protocol. For synthetic vitreous
ﬁbers, the European Commission established
TABLE 3. Clearance Half-Times of Fibers
Weighted T1/2 ﬁbers,
Fiber Type L > 20 µm (d) Reference
Calidria chrysotile Serpentine asbestos 0.3 (Bernstein et al., 2003a)
Brazilian chrysotile Serpentine asbestos 2.3 (Bernstein et al., 2004)
Fiber B B01.9 2.4 (Bernstein et al., 1996)
Fiber A Glasswool 3.5 (Bernstein et al., 1996)
Fiber C Glasswool 4.1 (Bernstein et al., 1996)
Fiber G Stonewool 5.4 (Bernstein et al., 1996)
MMVF34 HT stonewool 6.0 (Hesterberg et al., 1998b)
MMVF22 Slagwool 8.0 (Bernstein et al., 1996)
Fiber F Stonewool 8.5 (Bernstein et al., 1996)
MMVF11 Glasswool 9.0 (Bernstein et al., 1996)
Fiber J X607 9.8 (Bernstein et al., 1996)
MMVF 11 Glasswool 13 (Bernstein et al., 1996)
Fiber H Stonewool 13 (Bernstein et al., 1996)
Canadian chrysotile Serpentine asbestos 11.4 (Bernstein et al., 2003b)
MMVF10 Glasswool 39 (Bernstein et al., 1996)
Fiber L Stonewool 45 (Bernstein et al., 1996)
MMVF33 Special purpose glass 49 (Hesterberg et al., 1998a)
RCF1a Refractory ceramic 55 (Hesterberg et al., 1998b)
MMVF21 Stonewool 67 (Hesterberg et al., 1998b)
MMVF32 Special purpose glass 79 (Hesterberg et al., 1998a)
MMVF21 Stonewool 85 (Bernstein et al., 1996)
Amosite Amphibole asbestos 418 (Hesterberg et al., 1998a)
Crocidolite Amphibole asbestos 536 (Bernstein et al., 1996)PULMONARY EFFECTS OF ASBESTOS 95
a directive that states that if the inhalation
biopersistence clearance half-time of a ﬁber is
less than 10 d, then it is not classiﬁed as a
carcinogen.
Berman et al. (1995) conducted a statisti-
cal analysis of results from 9 different asbestos
types in 13 separate studies. Due to limitations
in the characterization of asbestos structures in
the original studies, new exposure measures
were developed from samples of the origi-
nal dusts that were regenerated and analyzed
by transmission electron microscopy. Results
reported that while no univariate model was
found to provide an adequate description of
the lung tumor responses in the inhalation
studies, the measure most highly correlated
with tumor incidence was the concentration
of structures (ﬁbers) ≥20 µmi nl e n g t h .
However, using multivariate techniques, mea-
sures of exposure were identiﬁed that ade-
quately described the lung tumor responses.
Berman et al (1995) noted that potency
appeared to rise with increasing length, with
structures (ﬁbers) longer than 40 µm being
about 500 times more potent than structures
between 5 and 40 µm in length. Structures
<5 µm in length do not appear to make any
contribution to lung tumor risk. This analysis
found no marked difference in the potency of
chrysotile and amphibole toward the induction
of lung tumors. However, Berman et al. (1995)
stated that the mineralogy, i.e., the physico-
chemical characteristics and crystal structure,
appears to be important in the induction of
mesothelioma, with chrysotile being less potent
than amphiboles.
Recent studies on the serpentine asbestos
chrysotile showed that it is not biopersistent
in the lung (Bernstein et al., 2010; Roggli &
Vollmer, 2008). As serpentine is a naturally
occurring mined ﬁber, there appears to be
some differences in biopersistence depending
upon where it is mined. In addition, some
deposits of chrysotile are contaminated with
amphibole ﬁbers, which are highly bioper-
sistent. However, chrysotile, per se, lies on
the soluble end of this scale and ranges
from the least biopersistent ﬁber to a ﬁber
with biopersistence in the range of glass and
stonewools. It remains less biopersistent than
amphibole ﬁbers. The 90-d subchronic inhala-
tion toxicity study of chrysotile in rats showed
that at an exposure concentration 5000-
fold greater than the U.S. ACGIH (American
Conference of Industrial Hygienists) threshold
limit value of 0.1 f(WHO)/cm3, chrysotile pro-
duced no signiﬁcant pathological response.
In summary, recent well-designed inhala-
tion toxicity studies demonstrated that the
ﬁber toxicity paradigm of dose, dimension,
and durability in the lung is applicable to
asbestos ﬁbers. The existing database of ﬁber
toxicity studies suggests that human exposure
to respirable ﬁbers that are biopersistent in
the lung may induce signiﬁcant and persistent
pulmonary inﬂammation, cell proliferation, or
ﬁbrosis, and inhalation exposure to such ﬁbers
needs to be viewed with concern. Chrysotile
ﬁbers are less biopersistent than ceramic and
special-purpose glass ﬁbers and are consider-
ably less biopersistent than amphibole ﬁbers. In
contrast, amphibole asbestos ﬁbers, especially
ﬁbers longer than 20 µm, exhibit little clear-
ance once they are deposited in the deep lung.
Chronic inhalation studies showed that amphi-
bole ﬁbers are carcinogenic. However, despite
the fact that most chrysotile ﬁbers are cleared
rapidly, some small proportion of these ﬁbers
remains in the lung, and all of the asbestos
types were noted in animal models and in epi-
demiological studies to induce asbestosis and
lung cancer, especially in smokers.
MECHANISMS OF ACTION OF
ASBESTOS IN VITRO
As it became evident that prolonged expo-
sure to asbestos ﬁbers produced lung ﬁbrosis,
lung cancer, and mesothelioma, concern arose
regarding the potential adverse health effects of
ﬁbers in general. While epidemiology studies
suggested that some ﬁbers such as most SVF did
not present carcinogenic risks, the mechanisms
for the different hazards of ﬁber types were
not well understood. Research on mechanisms
of ﬁber toxicity was initially conducted to gain
a better understanding of how ﬁbers produce96 B. T. MOSSMAN ET AL.
harm and to provide a sound basis for health
protective measures. Toxicologists have used
both in vitro and in vivo assays to study ﬁber
toxicity. In vivo bioassays provide an under-
standing of how ﬁbers behave in the body,
and how the body’s various protective systems
react to inhaled ﬁbers. If in vivo bioassay expo-
sures are conducted via inhalation and with
realistic exposure levels, results might poten-
tially be used to assess the health risks for
humans. However, despite their great utility,
in vivo bioassays are relatively time-consuming
and expensive. In comparison, many investiga-
tors are attracted to in vitro cell culture assays
because they are relatively quick, inexpensive,
and are used to assess toxicity of small quan-
tities of many different ﬁber types and sizes,
which is not practical using in vivo bioassays.
Organ culture models of tracheal and bronchi-
olar epithelium have also been used to preserve
epithelial-interstitial structure. The advantages
and disadvantages of in vitro assays must be
carefully considered before the test results can
be used appropriately. This section reviews the
advantages and disadvantages of in vitro assays,
both in general and speciﬁcally using asbestos
and other ﬁbers. It is hoped that its content will
provide a balanced perspective on the appro-
priate use of in vitro results in assessing the
potential health risks of ﬁbers.
Advantages and Uses of In Vitro Assays
The main advantage of in vitro assays is that
they allow speciﬁc biological and mechanistic
pathways to be isolated and tested under con-
trolled conditions in ways that are not feasible
in the whole animal. In vitro tests of toxic-
ity yield data rapidly and provide important
insights and conﬁrmations of the mechanism of
in vivo effects (Oberdorster et al., 2005). With
in vitro assays, the molecular events that pro-
duce cellular effects can be studied (Donaldson
et al., 2009). Several potential pathogenic
mechanisms of ﬁber toxicity were identiﬁed
using in vitro assays (Mossman et al., 2007). In
particular, much is now known about the role
of ﬁber morphological and/or physicochemi-
cal properties on cellular responses (NIOSH,
2009). When used as a screening procedure,
in vitro assays identify potential toxic materials
for further investigation and assist in prioritiz-
ing ﬁbers for further in vivo testing (Bernstein
et al., 2005c; Hesterberg & Hart, 2001; NIOSH
2009; Vu et al., 1996).
Several cell lines were used to investi-
gate mechanisms of toxicity (Bernstein et al.,
2005c; Oberdorster et al., 2005). In vitro stud-
ies with pulmonary and pleural macrophages
demonstrated how “frustrated phagocytosis”
may be an important mechanism of ﬁber tox-
icity. Macrophages normally protect the body
from small pathogenic bacteria and viruses by
engulﬁng (phagocytosis) and digesting them.
Macrophages similarly attack inhaled ﬁbers
that reach the lung air sacs (alveoli). Data
showed that even when ﬁbers are too long
to be fully engulfed (>20 µm long), the
macrophage might still attempt phagocytosis.
This might lead to “frustrated phagocytosis”
where the macrophage membrane is pierced
by an end of the ﬁber, and the macrophage
then dies and releases its digestive enzymes,
reactive oxygen species (ROS), proteases, and
chemokines/cytokines, which then affect lung
tissues and other cell types, producing damage
and/or proliferation (Bernstein et al., 2005c;
Hesterberg & Hart, 2001; Mossman, 2003).
Cell lines such as bronchial and alveolar
epithelial cells were also used to investigate
the early pathogenic mechanisms such as chro-
mosomal damage, cell signaling (Shukla et al.,
2003a), and mechanisms of cell proliferation or
dysregulation of cell growth (Bernstein et al.,
2005c; Elespuru et al., 2009). The generation
of ROS and reactive nitrogen species (RNS)
was implicated in DNA damage, induction
of inﬂammatory cytokines and growth fac-
tors (Hei, 2003; NIOSH, 2009; Shukla et al.,
2003b). In vitro assays also allow the study
of speciﬁc signal transduction pathways lead-
ing to production of inﬂammatory cytokines,
growth factors, and regulators of the cell cycle
(Bernstein et al., 2005c; Castranova, 2003;
Oberdorster et al., 2005; Shukla et al., 2009).
Inﬂammatory cytokines promote the inﬂux of
inﬂammatory cells and affect lung epithelium
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Mechanisms of cell death by apoptosis
(programmed cell death) and necrosis (lytic
death) are also of interest after exposure to
asbestos ﬁbers because they may lead to com-
pensatory cell proliferation of surrounding cells
as well as metaplastic changes (Mossman et al.,
1980; Woodworth et al., 1983). Both apoptosis
and necrosis were observed in lung epithe-
lial cells in culture (Buder-Hoffmann et al.,
2009; Liu et al., 2010; Mossman & Sesko,
1990; Panduri et al., 2006; Shukla et al., 2009;
Yuan et al., 2004), but whether these phenom-
ena occur after exposures to asbestos ﬁbers
by inhalation is unclear. However, these in
vitro models using amphibole types of asbestos
(crocidolite, amosite) showed that the duration
of cell signaling pathways, speciﬁcally extra-
cellular signal-regulated kinases (ERK), regu-
lates whether cell proliferation or death occurs.
Moreover, ERK and protein kinase C activa-
tion, as well as mitochondrial- and p53-related
death pathways, are all involved in death or
injury of epithelial cells via elaboration of oxi-
dants occurring after incomplete phagocyto-
sis of long ﬁbers or iron-dependent reactions.
Finally, mechanisms of secretion of extracel-
lular matrix components and matrix metallo-
proteinases (MMP) by lung epithelial cells and
ﬁbroblasts were studied to understand the early
development of ﬁbrotic lesions (Shukla et al.,
2000).
Disadvantages of In Vitro Assays
The fundamental disadvantage of in vitro
assays is that they often employ very high non-
physiological concentrations of ﬁbers. Further,
even with the added advantage of using
organ cultures or cocultures, in vitro assays do
not take into account the complex interac-
tions of the different cell types and immuno-
logic systems found in the whole animal and
lung (Holsapple et al., 2009; Oberdorster
et al., 2005). Similarly, systemic or multi-organ
responses, such as the complete inﬂammatory
response, cannot be studied (Donaldson et al.,
2009; Oberdorster et al., 2005). Furthermore,
toxicokinetics cannot be studied in systems in
vitro because the in vivo systems for absorption,
distribution, uptake, and metabolism are not
present. Although dose-response studies can
be performed and subsequently validated in
subchronic inhalation studies (Shukla et al.,
2004b), ﬁber doses per cell in studies in vitro
are generally far greater than can be achieved
by in vivo bioassays (Bernstein et al., 2005c;
Oberdorster et al., 2005). Because of the
dosage disparities, cellular responses observed
with in vitro assays may not correlate with
effects that occur at much lower cellular doses
in vivo. Most in vitro tests have not been
validated or correlated with adverse effects
observed in vivo (Hartung, 2010; Oberdorster
et al., 2005; Vu et al., 1996). Validation is
also difﬁcult for most in vitro tests because the
tests do not have standardized ﬁber prepara-
tions, protocols, or outcomes (Bernstein et al.,
2005c).
The responses with in vitro assays are mea-
sured after a few hours or days, while in
vivo responses to biopersistent ﬁbers are sus-
tained over several weeks or months. With
in vitro assays, the tests are too short of
duration for biopersistence of ﬁbers to come
into play (Bernstein et al., 2005c). Research
on SVF demonstrated that biopersistence with
prolonged inﬂammation is a key mechanism
of ﬁber toxicity (Hesterberg & Hart, 2000,
2001). Similarly, biopersistence is an impor-
tant mechanism differentiating the potential
adverse health effects of chrysotile asbestos
from the more durable amphibole asbestos
types (Hesterberg, 2009). Biopersistence of
ﬁbers is related to the site in the lung and
rate of deposition, rates of clearance by alveo-
lar macrophages or mucociliary transport, their
lack of solubility in lung ﬂuids (durability),
their breakage rate and pattern (longitudinal
or transverse), and their rates of transport
across biological membranes (NIOSH, 2011).
Thus, many of the processes involved in the
biopersistence of ﬁbers cannot be assessed in
vitro.
Another problem with in vitro cell assays
is that immortalized or transformed (malig-
nant) cell lines most commonly used can
exhibit abnormal biology (Holsapple et al.,
2009). Since the desired target cells are98 B. T. MOSSMAN ET AL.
difﬁcult to standardize and maintain, investi-
gators often use immortalized cell lines (pre-
neoplastic), which clearly do not represent the
in vivo situation (Devlin, 2009). For example,
cell lines derived from human lung tumors
(e.g., A549 cells), spontaneously immortalized
cells, or cells transfected with viral oncopro-
teins (e.g., Met5A) possess changes that may
alter their genotoxic, apoptotic, or prolifer-
ative responses to ﬁbers (Bernstein et al.,
2005c). For these reasons, use of primary and
telomerase-immortalized human lung epithe-
lial and mesothelial cells has been advocated
for robust assays (Shukla et al., 2009) In vitro
test exposure conditions also may not match
those occurring in vivo, e.g., pH, speciﬁc pro-
tein content, etc. (Walker & Bucher, 2009).
Both pH and protein content affect the sur-
face properties of ﬁbers and their interaction
with cells and tissues. Changes in those proper-
ties may lead to results that are vastly different
between in vitro tests and in vivo bioassays
(Oberdorster et al., 2005).
Another issue for in vitro assays is the ques-
tionable extrapolations of ﬁber dose to that
occurring in vivo and the general lack of dose-
response studies. Most publications compare
ﬁbers on a mass basis, which might not be an
appropriate metric for evaluation of compara-
ble potency between ﬁber types.
Despite the disadvantages just highlighted
with in vitro tests, especially with ﬁbers, there
is a substantial movement in toxicology toward
in vitro testing (Devlin, 2009; Hartung, 2010;
Holsapple et al., 2009; Krewski et al., 2010;
Walker & Bucher, 2009). Toxicologists recog-
nize that the time when in vitro tests supplant
in vivo bioassays is at least 10–20 yr off and will
require major investments in research funding
(Andersen et al., 2010).
In Vitro Versus In Vivo Assays for
Asbestos and Other Fibers
Research on asbestos ﬁbers provides one
example of how in vitro test results on tox-
icity do not correlate with in vivo bioassay
ﬁndings. In most in vitro assays, chrysotile
asbestos produces toxicity that is similar or
greater than observed with amphiboles (e.g.,
crocidolite, amosite) (Mossman, 1993; WHO,
1998). This does not agree with the in vivo
laboratory studies and human epidemiology,
which indicate that the amphiboles are more
pathogenic than chrysotile asbestos, especially
in mesothelioma (Yarborough, 2006, 2007;
NIOSH, 2009). However, it is important to
note that the dosimetry in most past experi-
ments is based on equal weights of ﬁbers that
may reﬂect more numbers of ﬁbers and greater
surface areas of chrysotile (Mossman et al.,
1990). In vitro testing with other ﬁbers may
produce results that suggest hazards that may or
may not be present after inhalation. For exam-
ple, in vitro tests on ﬁberglass suggested far
greater toxicity (i.e., false-positive) than what is
observed in vivo (Hart et al., 1994; Hesterberg
& Hart, 2001). On the other hand, in the case
of single-walled nanotubes, in vitro tests indi-
cate low toxicity when in vivo bioassays indi-
cate otherwise (i.e., false-negative) (Donaldson
et al., 2009).
In summary, in vitro tests have proven to
be useful tools for mechanistic investigations of
ﬁbertoxicityandothercellresponses.However,
in vitro tests also have some disadvantages that
limit their utility in health risk assessment. At
this time, in vitro tests can serve as an adjunct
to and be predictive of the necessity for in vivo
studies, but cannot replace inhalation studies.
For these reasons, when trying to infer health
risks, caution needs to be used when assessing
the results of in vitro analysis using ﬁbers, espe-
cially different types of asbestos and SVF. The
NIOSH Roadmap Plan concluded that while
in vitro experiments are invaluable for under-
standingﬁber/cellinteractions,nonehavebeen
validatedforuseaspredictorsofcarcinogenicity
(NIOSH, 2009). However, this may be possible
in the future after one or more assays are val-
idated as predictors of carcinogenic potential
(Shukla et al., 2009).
LUNG CARCINOMAS—EPIGENETIC
AND GENETIC EFFECTS
Asbestos has long been known as a potent
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1998; Russi & Cone, 1994; Blot & Fraumeni,
1996). While tobacco smoke is clearly the
single greatest risk factor for lung cancer,
increased risks for lung cancer were observed
in both nonsmokers and smokers exposed to
asbestos (Blot & Fraumeni, 1996; Selikoff et al.,
1968). Moreover, epidemiologic evidence on
some cohorts demonstrated that smoking and
asbestos exposure have a more than additive
action in inducing lung cancer (Selikoff et al.,
1968; Vainio & Boffetta, 1994). The relation-
ship between these exposures has been termed
“synergistic,” meaning that they act in a multi-
plicative fashion (Rothman, 1976).
Quantiﬁcation of the magnitude of these
risks is problematic as they clearly are dose,
time, and ﬁber size and type dependent.
Moreover, individual sensitivity and coexpo-
sure to other cocarcinogenic agents in the
workplace may be important. The animal stud-
ies described previously are generally con-
ducted in inbred strains, whereas humans
are genetically heterogenous. Recent deep
sequencing studies indicate that sensitivity to
certain drugs and other agents may be linked to
rare alleles that are not identiﬁed in genome-
wide association studies. Therefore, it is likely
that inhalation of asbestos ﬁbers in humans
results in a broad range of responses that vary
with genotype (e.g., individual sensitivity), as
well as gender and behavioral and nutritional
inﬂuences. Hence, caution needs to be exerted
when extrapolating mechanisms from animal or
in vitro studies to disease endpoints that occur
in humans individually.
Epidemiologic data addressing the lung
cancer risk from asbestos exposure and the
accepted interaction with tobacco smoke
exposure have been intensively analyzed, but
this interaction appears to hold for all histologic
subtypes (Vainio & Boffetta, 1994). Further,
although fraught with uncertainty, the dose
extrapolations are also consistent with a linear
dose-response for the interactive risk. Recent
models also suggest that attained age is an
important risk modiﬁer, at least in the case
of chrysotile asbestos exposure (Richardson,
2009). While the precise mechanisms of action
of asbestos acting as a lung carcinogen either
alone or in combination with tobacco smoke
exposure remain unclear, recent molecular
investigations are beginning to suggest fruitful
avenues for research (Heintz et al., 2010).
Asbestos has long been known to produce
numerical and structural chromosomal aberra-
tions (CA), aneuploidy, breakage of DNA, and
impairment of cell division in various cell types
in vitro (Huang et al., 2011, this issue; HEI,
1991). Genotoxicity is observed most com-
monly at lethal concentrations of asbestos.
Moreover, it is unclear whether genotoxicity is a
mechanism of asbestos carcinogenicity in lung
epithelial cells. In most of the studies, using
lung cells, a single type and/or one high con-
centration of asbestos was used, i.e., crocidolite
(Ault et al., 1995; Jensen et al., 1996; Cole
et al., 1991) or amosite in various amounts
(Kamp et al., 1995). Other studies using human
bronchial epithelial cells exposed to crocidolite
or chrysotile asbestos at various concentrations
(Kodama et al., 1993) have proven negative.
Dose-response studies revealed the absence
of statistically signiﬁcant gene or chromoso-
mal endpoints, aneuploidy, or CA in Chinese
hamster ﬁbroblasts (V79 cells) at lowest con-
centrations of crocidolite or chrysotile (Palekar
et al., 1987).
Chrysotile and crocidolite asbestos induce
changes in gene expression in homeostatic
pathways, as well as signaling pathways critical
to the induction of cancer, such as nuclear fac-
tor (NF)-κB inﬂammatory cascade, TP53 regu-
latory pathways, activator protein-1 (AP-1) and
mitogen-activated protein kinases (MAPK) cas-
cades, or PDGF (platelet-derived growth factor)
pathways (Janssen et al., 1997; Mossman et al.,
2006; Shukla et al., 2004a, 2006; Brody et al.
1997). Finally, investigations of human tumors
in asbestos-exposed lung cancer patients found
that asbestos exposure was associated with spe-
ciﬁc somatic anomalies, including the k-ras
oncogenic pathway (Nymark et al., 2008),
loss of chromosome 3p (Marsit et al., 2004;
Nymark et al., 2006) and FHIT gene deletion
(Nelson et al.,1998; Pylkkanen et al., 2002),
loss of 19p13 (Nymark et al., 2009; Ruosaari
et al., 2008) and 2p16 (Kettunen et al., 2009),
alterations in the TP53 pathway, and deletion100 B. T. MOSSMAN ET AL.
or epigenetic activation of the gene encoding
p16 (Kim et al., 2001; Kraunz et al., 2006). It
is noteworthy that the vast majority of investi-
gations into lung cancer, including those now
delineating the spectrum of both genetic and
epigenetic gene activation and inactivation, do
not report (or perhaps have no knowledge of)
asbestos exposure or lung content and types
of ﬁbers. This has greatly hampered the study
of the distinct nature of asbestos-induced lung
cancer and is the single greatest barrier to
accumulation of knowledge in this ﬁeld.
Husgafvel-Pursiainen et al. (1993) ﬁrst sug-
gested that asbestos exposure enhanced the
association of tobacco smoke exposure and
the occurrence of k-ras mutations in adeno-
carcinoma. Mutations at k-ras are primarily G
to T transversions at codon 12, and this type
of alteration (transversion mutation) was asso-
ciated with the action of polycyclic aromatic
hydrocarbons (PAH) and likely represents the
actionoftobaccocarcinogensatthecellularlevel
(Denissenko et al., 1996). Additional studies
conﬁrmedthisobservationofasbestosenhance-
ment of smoking-related mutations (Husgafvel-
Pursiainen et al., 1995; Nelson et al., 1999;
Wang et al., 1995). However, potential con-
founding by histology may obscure the ability to
detect associations (Husgafvel-Pursiainen et al.,
1999).Inaddition,Nelsonetal.(1999)reported
thatthesetypesoftransversionmutationsatk-ras
occur in asbestos-exposed individuals without
evidence of ﬁbrotic alterations. This molecu-
lar evidence implies that asbestos exposure is
relatedtolungcancerintheabsenceofasbesto-
sis. In addition, p53 mutations and aberrant
protein expression in lung cancer have been
associated with asbestos exposure (Husgafvel-
Pursiainen et al., 1995; Liu et al., 1998a; Wang
et al., 1995). The prevalence of G:C to T:A
transversion mutations at p53 is enhanced by
asbestos exposure in a fashion related to com-
bined asbestos and tobacco carcinogen dose
(Wang et al., 1995). This adds further molecular
evidence to the postulation that asbestos ﬁbers
act by enhancing the delivery of PAH carcino-
gens and increase their DNA adduct formation
in epithelial cells of the lung (Eastman et al.,
1983).
Loss of chromosome 3p and alterations
of the FHIT gene have been reported
to be associated with asbestos exposure
(Marsit et al., 2004; Nymark et al., 2006;
Wikman et al., 2007; Nelson et al., 1998;
Pylkkanen et al., 2002). This region is a frag-
ile site, and asbestos may act preferentially
to disrupt fragile DNA. Alternatively, there
may be additional phenotypes to clones with
these deletions (e.g., epigenetic perturbations
enhance asbestos-associated genotoxicity) that
remain obscure. Kettunen et al. (2009) also
showed that locus-speciﬁc copy number loss
and allelic imbalance at 2p16.3-p16.2 are asso-
ciated with asbestos exposure in lung tumors,
whereas low-level copy number gains at 2p21
are common in lung cancer in general. Indeed,
these data supplement previously identiﬁed
asbestos-associated alterations in other chro-
mosomal regions, such as 19p13 and 9q33.1
(Nymark et al., 2009; Ruosaari et al., 2008).
Epigenetic changes at p16 are also corre-
lated with carcinogen exposure (Kraunz et al.,
2006; Kim et al., 2001) and further suggest
that asbestos-speciﬁc genetic and epigenetic
changes may exist (Dammann et al., 2005). The
association of epigenetic changes with asbestos
exposure in mesothelioma (Christensen et al.,
2008, 2009), in parallel with the known sig-
niﬁcant array of epigenetic changes that occur
in lung cancer (Pfeifer & Rauch, 2009) argues
that asbestos, acting as a lung carcinogen, also
contributes in an important fashion to epige-
netic gene alterations, deﬁned as changes in
methylation or autylation of genes. However,
it is difﬁcult to determine effects of speciﬁc
types of asbestos in these studies because
of mixed exposures to asbestos in humans.
Finally, expression array experiments, designed
to speciﬁcally delineate asbestos-associated
pathway disruption, were recently observed
(Ruosaari et al., 2008). These data are consis-
tent with prior studies, again suggesting that
speciﬁc pathways may be targeted for disrup-
tion by asbestos.
All of these data clearly suggest that
asbestos-associated lung cancers have at least
some differences in gene pathways that are
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in genetic change in somatic genes. The
precise mechanisms responsible for the action
of asbestos as a lung carcinogen either alone
or in combination with tobacco smoke remain
the subject of considerable scrutiny. Studies
using a molecular epidemiologic approach are
suggesting that combined exposures result in
more DNA changes of the particular type pro-
duced by tobacco carcinogens. In addition,
evidence now suggests that molecular changes
may be independent of ﬁbrosis and implies that
the complex pathways for the development of
ﬁbrosis and lung cancer may be, at least in
some critical ways, distinct. Finally, there is lit-
tle doubt that epigenetic changes play a crucial
role in asbestos-associated cancer, but this is
poorly studied and not linked to speciﬁc types
of asbestos.
In Vivo Studies of Inﬂammation and
Oxidants as Mediators of
Asbestos-Promoted Lung Diseases
Asbestos ﬁbers also may act at subse-
quent stages in the protracted development
(generally >20 yr) of lung cancers and ﬁbro-
sis, as do classical tumor promoters, such as
phorbol esters (Mossman et al., 1985, 1990).
These agents primarily induce inﬂammation,
cell proliferation, and further genetic instability.
Inhaled asbestos ﬁbers elicit acute and chronic
inﬂammatory responses at sites of deposition
along airways and in alveolar spaces. These
responses are linked to development of both
malignant (lung cancer and mesothelioma) and
nonmalignant (asbestosis) lung and pleural dis-
eases (Bringardner et al., 2008; Mossman &
Churg, 1998). Human and animal studies
demonstrated that ROS generation following
exposures to various asbestos types is essen-
tial in signaling for cytokine-dependent innate
immune responses (Bringardner et al., 2008;
Dostert et al., 2008; Haegens et al., 2005;
Mossman et al., 2006), lung matrix remodeling
(Bringardner et al., 2008), and cell prolifera-
tion or transformation (Shukla et al., 2003b).
It is evident that asbestos elicits pathogenic
ROS-dependent cell signaling and tissue matrix
remodeling through multiple mechanisms as
oxidants are generated both directly from
surface reactions on the ﬁbers and indirectly
following partial engulfment by leukocytes and
epithelial cells. These sources of oxidants ini-
tiate secondary and prolonged inﬂammatory
signaling for recruitment of innate immune
responses and tissue remodeling. This section
focuses on in vivo studies of mechanisms of
oxidant generation by asbestos ﬁbers and the
consequent oxidant-dependent signaling path-
ways that may underlie the pathogenesis of
asbestos promoted lung diseases.
Asbestos-promoted inﬂammation and
ﬁbrosis occur in a dose-related fashion with
more striking severity of injury, cell pro-
liferation, early response protooncogene
expression, and ﬁbrosis by crocidolite com-
pared to chrysotile in subchronic inhalation
exposures (Shukla et al., 2004b; Quinlan et al.,
1994, 1995; BeruBe et al., 1996). Fiber biop-
ersistence and the capacity to generate ROS
appear important in vivo (Mossman & Churg,
1998; Ghio et al., 2008). Various types of
asbestos spontaneously catalyze the formation
of ROS in aqueous solutions or after uptake by
cells (Shukla et al., 2003b; Ghio et al., 2008).
Moreover, in vitro oxidant production from
asbestos ﬁbers increases with the concentration
of iron (Fe) and other redox-active cations in
the lung tissue that catalyze Fenton reactions
(Shukla et al., 2003b; Ghio et al., 2008). Iron
may be mobilized from asbestos ﬁbers, the
ﬁbers may adsorb Fe extracellularly in the
lung or pleura, and asbestos ﬁbers may alter
lung Fe homeostasis with a net increase in
Fe accumulation (Ghio et al., 2008, 2009).
Fenton-like reactions reduce molecular oxygen
to superoxide that is catalytically dismuted
to hydrogen peroxide (H2O2) by intracellu-
lar and extracellular superoxide dismutases.
Further reduction of H2O2 via reaction with
superoxide in Fe-driven Fenton-like reactions
forms highly reactive hydroxyl radical on the
surface of the ﬁbers or at sites where leached
Fe(II) is free and not sequestered (Mossman &
Churg, 1998; Ghio et al., 2008). Alternatively,
evidence from genetic mouse models indicates
that H2O2 generated either from ﬁbers after
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bursts is converted to hypochlorous acid
(HOCl) in a reaction catalyzed by myeloperox-
idase (Haegens et al., 2005). Evidence from a
number of genetic rodent models with selected
overexpression or absence of pro- or antioxi-
dant enzymes suggests that that these reactions
occur in rodent lungs after in vivo inhalation or
intratracheal instillation of asbestos or silicates,
but not inert dusts (Mossman & Churg, 1998;
Ghio et al., 2008). Human studies also provide
signiﬁcant evidence of persistent oxidative
stress and oxidant generation in patients with
asbestos-related lung diseases (Ghio et al.,
2008; Chow et al., 2009).
Direct generation of ROS by Fe or other
metals associated with asbestos ﬁbers, how-
ever, cannot account for all oxidative stress
from inhaled asbestos. This additional oxidant
stress derives from cellular respiratory bursts
generated as ﬁbers contact or are engulfed by
alveolar macrophages, inﬁltrating neutrophils,
and airway epithelial cells (Mossman & Churg,
1998; Bringardner et al., 2008). Longer, more
ﬁbrogenic ﬁbers of asbestos produce a frus-
trated, ineffective phagocytosis and more pro-
tracted elevations in release of ROS (Mossman
& Churg, 1998). The respiratory burst is medi-
ated by activation of phagocyte or epithe-
lial cell NADPH oxidases, multimeric protein
complexes that generate superoxide and sub-
sequent H2O2 when stimulated by microbe
and particle phagocytosis, or receptor sig-
naling (Dostert et al., 2008; Hordijk, 2006;
Quinn et al., 2006). As indicated earlier, neu-
trophil myeloperoxidase, either within the cell
or leached across the epithelial cell barriers,
catalyzes conversion of H2O2 to the more
potent oxidant HOCl. In addition, myeloper-
oxidase is a source of nitric oxide-derived oxi-
dants when sufﬁcient nitrate and nitrite are
present (Gaut et al., 2002). Reactive nitro-
gen species (RNS) are increased in alveo-
lar macrophages recovered from rats exposed
by inhalation to ﬁbrogenic concentrations of
asbestos (Quinlan et al., 1998). These eleva-
tions are linked to enhanced production of
nitrate and nitrite (Thomas et al., 1994), as
well as increased expression of inducible nitric
oxide synthease (iNOS) (Quinlan et al., 1998).
Importantly, nitration of proteins, a hallmark of
inﬂammation, is elevated in the lungs of rats
after inhalation of asbestos, and mice that lack
myeloperoxidase display reduced asbestos-
induced lung inﬂammation and epithelial cell
remodeling relative to their myeloperoxidase
competent littermates (Haegens et al., 2005)
Nitric oxide (NO.) released by inﬂammatory
cells might also react with O.−
2 to form
peroxynitrite (ONOO−). ONOO− produces
nitration of tyrosine residues on proteins and
thereby modiﬁes protein function. Nitrated
proteins were identiﬁed in lung tissue follow-
ing exposure to asbestos ﬁbers (Tanaka et al.,
1998). Furthermore, ONOO− produced dys-
regulation of growth factor receptor tyrosine
kinase signaling (Zhang et al., 2000). Therefore,
ONOO− generation and subsequent tyrosine
nitration leading to protein dysfunction appear
to contribute to disease progression following
asbestos-induced lung injury.
It is important to note that the acute
inﬂammatory response to asbestos ﬁbers
elicits more protracted inﬂammatory cell
inﬂux through gene induction and expres-
sion of pro-inﬂammatory cytokines (Mossman
& Churg, 1998; Bringardner et al., 2008).
Oxidants derived from Fe-catalyzed reactions
or asbestos-activated NADPH oxidase may
signal for cytokine-mediated responses by acti-
vating the macrophage Nod-like receptor pro-
tein (Nalp3) inﬂammasome that elicits an
IL1β-driven innate immune response (Dostert
et al., 2008). In a recent in vivo study, mice
that lacked Nalp3 and inhaling asbestos dis-
played reduced inﬁltration of a number of cell
types, including lymphocytes, eosinophils, and
neutrophils, as well as decreased expression
of cytokines that would elicit this inﬁltration
(Dostert et al., 2008). Inhibition or elimination
of NADPH oxidase activity or expression pre-
vented asbestos-induced inﬂammasome acti-
vation and IL1β expression, as did chelating
Fe from the asbestos ﬁbers. It is signiﬁcant that
not all asbestos-induced cytokine expression
or responses in these studies were reduced in
Nalp3 –/– mice, indicating that additional sig-
nals are generated to elicit asbestos-induced
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Sabo-Attwood et al. (2005) also suggested this
in gene proﬁling experiments on whole lungs
of mice in a chrysotile asbestos model of
epithelial cell proliferation, inﬂammation, and
ﬁbrogenesis.
The role of inﬂammation, especially the
transient acute phase of cellular inﬁltration,
in the pathogenesis of particle-induced ﬁbro-
sis has been controversial (Mossman & Churg,
1998; Bringardner et al., 2008). This contro-
versy is fueled by a lack of prolonged cellular
inﬁltrates and the fact that immunosuppressive
therapies fail to treat the disease (Bringardner
et al., 2008). However, localized inﬂamma-
tory responses promote ﬁbroblast dysfunction,
and epithelial cell proliferation may be a criti-
cal factor in promoting asbestos-related disease
(Manning et al., 2008). Localized dysfunction
from pro-ﬁbrotic agents, including asbestos,
may result in further inﬂammatory responses,
matrix remodeling, release of matrix-bound
ligands and cytokines, localized activation of
growth factor signaling, and altered tissue vas-
cularization (Bringardner et al., 2008) There
is signiﬁcant evidence that implicates local-
ized ROS generation in asbestos-induced stim-
ulation of each of these processes (Shukla
et al., 2003b). It is well recognized that inhala-
tion of asbestos ﬁbers leads to focal epithe-
lial cell proliferation and alveolar macrophage
activation at sites of deposition, especially at
impacted airway and alveolar duct bifurca-
tions (Liu et al., 1997, 1998b; BeruBe et al.,
1996; Robledo et al., 2000; Brody et al., 1997;
Mossman & Churg, 1998; Shukla et al., 2000;
Brody & Roe, 1983; Sullivan et al. 2008).
In vitro and in vivo data also indicate that
the asbestos-impacted epithelial cells signal for
transcriptional induction of cytokines that initi-
ate the localized inﬂammatory and proliferative
responses (Mossman et al., 2006; Hoyle &
Brody, 1996; Janssen et al., 1997). Persistent
increases in nuclear localization of NF-κB, a
primary transcription factor regulating cytokine
expression, were observed in interstitial and
pleural cells of rats long after the acute inﬂam-
matory response to crocidolite asbestos sub-
sided (Janssen et al., 1997). Similarly, persistent
localization of extracellular signal-regulated
kinases (ERK) and AP-1 factor activation is
an epithelial cell-speciﬁc response in various
asbestos inhalation models (Mossman et al.,
2006; Cummins et al. 2003). These processes
result in cytokine and stress gene induction
and are reduced by antioxidants (Shukla et al.,
2004b). In addition, expression of the well-
known tumor suppressor protein p53 is upreg-
ulated at sites of asbestos injury consequent to
inhalation of chrysotile asbestos by rats (Mishra
et al.,1997).
In conjunction with cellular activation,
oxidative matrix degradation, or oxidant acti-
vation of matrix remodeling proteins, asbestos
ﬁbers activate growth factor receptor lig-
ands and inﬂammatory mediators that pro-
mote cell proliferation and tissue remodeling.
Tissue growth factor-β (TGF-β) is one exam-
ple of a potent proﬁbrotic stimulant of matrix
remodeling and ﬁbroblast proliferation that is
affected by asbestos ﬁbers (Liu & Brody, 2001;
Mossman & Churg, 1998; Sullivan et al., 2008).
TGF-β is deposited on alveolar surfaces in
a latent form bound in the matrix by latent
associated peptide (LAP) (Bringardner et al.,
2008; Sullivan et al., 2008). Sullivan et al.
(2008) recently provided in vivo evidence that
complemented earlier in vitro studies showing
that asbestos-derived oxidants promote degra-
dation of the TGF-β complex with LAP to
provide active ligand for the TGF-β recep-
tor (Pociask et al., 2004). TGF-β often acts
in conjunction with matrix-bound connective-
tissue growth factors to coordinate ﬁbroblast
proliferation, migration, and collagen synthe-
sis (Sullivan et al., 2008). In addition, asbestos
exposures led to increased signaling through
epithelial-cell epidermal growth factor recep-
tors (Manning et al., 2002), which might be
stimulated both by the ﬁbers themselves and
by TGF-α released from the matrix.
In summary, inhalation of asbestos ﬁbers
may result in a number of pulmonary dis-
eases that are mediated in part by acute and
chronic inﬂammatory responses. Generation of
ROS through surface reactions of the ﬁbers,
inappropriate Fe mobilization in the lung,
and stimulation of cellular oxidant-generating
enzymes are central to these inﬂammatory104 B. T. MOSSMAN ET AL.
responses. It is evident that asbestos-induced
oxidative stress promotes pulmonary inﬂam-
mation through stimulation of innate immune
responses and matrix degradation that liberates
additional inﬂammatory mediators. In addi-
tion, long after acute inﬂammatory responses
have subsided, focal signaling results in tis-
sue and cellular release of growth factors and
cytokines that promote chronic inﬂammation,
ﬁbrogenesis, matrix remodeling, and prolif-




Various inhaled particles and ﬁbers pro-
duce injury to the lungs, but asbestos ﬁbers
have unique physical and chemical charac-
teristics that make them particularly insidious
(Bonner, 2007). Inhaled asbestos ﬁbers deposit
initially at the bronchiolar–alveolar duct (BAD)
regions of the lung in rats and mice (Brody,
1993). As summarized previously, in rodent
models, inhaled ﬁbers induce proliferation of
epithelial and mesenchymal cell populations
(Brody et al., 1997), and early signaling events
are likely to begin with epithelial cell activa-
tion (Manning et al., 2002). One of the ﬁrst
signaling events triggered on the epithelial sur-
face of the BAD region is the cleavage of
complement C5 to C5a, a potent chemoattrac-
tant for alveolar macrophages (Warheit et al.,
1986). Macrophages migrate to sites of ﬁber
deposition within 1 d of inhalation exposure,
engulﬁng short ﬁbers (less than approximately
10 µm in length in rats) and removing these
ﬁbers via the mucociliary apparatus or via the
pulmonary lymphatic system that may trans-
port the same ﬁbers to other lymph nodes,
the pleural space, and mesothelial surfaces of
the pleural (Boutin et al., 1996) and peritoneal
cavities (Dodson et al., 1990). Longer ﬁbers
may be retained more commonly in the lung
due to the inability of macrophages to remove
them via these processes. In addition, asbestos
ﬁbers not removed by macrophages penetrate
the epithelium over time and move into the
interstitial spaces and thereby interact directly
with ﬁbroblasts, smooth muscle cells, and other
interstitial cell types (Brody et al., 1981; Chang
et al., 1988; Coin et al., 1992).
Macrophage–Fibroblast Signaling During
Asbestosis: PDGF as a Mediator of
Proliferation
As mentioned earlier, macrophages play a
central role in the clearance of inhaled asbestos
ﬁbers from the lungs. Macrophage-mediated
clearance is effective for short ﬁbers, but not
longer ﬁbers that persist to chronically irritate
lung tissues and stimulate macrophages and
other pulmonary cell types to produce sol-
uble factors that play roles in tissue repair,
remodeling, or chronic disease (see earlier dis-
cussion). One such factor is platelet-derived
growth factor (PDGF), a polypeptide that binds
to speciﬁc receptors on ﬁbroblasts to stimu-
late cell migration and proliferation (Bonner,
2004). A number of studies indicate that PDGF
plays a role in asbestosis. For example, lev-
els of PDGF-A and -B mRNAs are increased
in rat lung following an inhalation exposure
to chrysotile asbestos (Liu et al., 1997). These
in situ hybridization experiments show that
PDGF-A and -B chain RNAs are localized pri-
marily in macrophages and bronchioalveolar
epithelial cells at sites of initial ﬁber deposi-
tion and lung injury (Liu et al., 1997). Two
distinct molecular masses of PDGF-like factors
(approximately 34 and 16 kD) are secreted by
asbestos-stimulated rat alveolar macrophages
in vitro. These factors were primarily iden-
tiﬁed as PDGF-B chain molecules and rep-
resented the majority of macrophage-derived
mitogenic activity for cultured rat lung ﬁbrob-
lasts. Macrophage-derived PDGF was identi-
ﬁed as a major chemotactic factor for rat
lung ﬁbroblasts. The PDGF-B chain isoforms
are more potent as ﬁbroblast chemoattractants
as compared to PDGF-A. Asbestos ﬁbers also
inﬂuence the expression of PDGF receptors on
rat lung ﬁbroblasts in vitro, and this receptor is
also increased in the lungs of mice in vivo fol-
lowing asbestos inhalation (Lasky et al., 1998).
In addition to asbestos regulating PDGF ligand
and receptor levels, ﬁbers also modulate thePULMONARY EFFECTS OF ASBESTOS 105
expression of alpha-2-macroglobulin, a PDGF-
binding protein (Bonner and Brody, 1995).
While there is currently no effective treatment
for the pathogenesis of asbestosis, PDGF signal-
ing and proliferative responses can be inhibited
by the PDGF receptor kinase inhibitor ima-
tinib mesylate (Gleevec), which shows some
promise as an antiﬁbrotic therapy in exper-
imental animal models of ﬁbrosis (Ingram &
Bonner, 2006).
Macrophage–Fibroblast Signaling During
Asbestosis: TNF-α and TGF-β1a s
Mediators of Matrix Production
Macrophages are also a rich source of
TGF-β1, which promotes collagen deposition
by ﬁbroblasts and thereby serves as a potent
proﬁbrogenic mediator (Perdue & Brody, 1994;
Brass et al., 1999). Immunohistochemistry stud-
ies demonstrated that TGF-β1 is expressed
primarily in macrophages and the bronchoalve-
olar epithelial cells at BAD regions where
asbestos ﬁbers accumulate after inhalation
(Perdue & Brody, 1994). Increased TGF-β1
occurs after the PDGF-induced proliferative
phase of pulmonary ﬁbrogenesis. Fibroblasts
treated with TGF-β1 undergo growth arrest and
downregulate PDGF receptor expression, but
enter a synthetic phase wherein collagen and
other matrix proteins are produced (Bonner &
Brody, 1995). These extracellular matrix pro-
teins deﬁne the ﬁbrotic lesion. Several lines
of evidence indicate that TGF-β1 produc-
tion is dependent on the expression of tumor
necrosis factor (TNF)-α. First, human alveo-
lar macrophages exposed to chrysotile asbestos
ﬁbers in vitro demonstrated a signiﬁcant rise in
release of TNF-α followed by TGF-β1s e c r e -
tion (Liu & Brody, 2001). Second, administra-
tion of chrysotile asbestos ﬁbers to rats results
in ﬁbrosis, which corresponds to increased
TGF-β1 and which is preceded by an elevation
in bronchoalveolar lavage (BAL) ﬂuid TNF-α
expression (Liu & Brody, 2001). Third, C57BL6
mice develop asbestos-induced ﬁbroprolifera-
tive lesions at the alveolar duct bifurcations,
the predominant site of ﬁber deposition where
TNF-α expression is localized to macrophages
and alveolar epithelial cells in this murine
model of chrysotile asbestos-induced ﬁbroge-
nesis (Brass et al., 1999) However, J129 mice,
which do not develop macrophage inﬁltra-
tion or ﬁbroproliferative lesions in response to
asbestos, do not increase their TNF-α expres-
sion, as assessed by in situ hybridization and
immunohistochemistry (Brass et al., 1999).
In addition, double TNF-α receptor knock-
out mice are protected from asbestos-induced
ﬁbrosis and do not have elevated levels of
TGF-β1 (Liu & Brody, 2001). Finally, two sep-
arate studies on the signal transduction process
through which TNF-α mediates the expression
of TGF- β1 showed that signaling goes through
a MEK-ERK pathway and the AP-1 transcrip-
tion factor (Sullivan et al. 2005, 2009). Thus,
there is convincing evidence that suggests a crit-
ical role for TNF-α in the regulation of TGF-β1
production and the pathogenesis of asbestosis.
Epithelial–Fibroblast Signaling During
Asbestosis: EGFR Ligands
While initially much attention focused
on the role of macrophages in mediating
ﬁbroblast proliferation and collagen deposi-
tion, later investigations emphasized the role
of the epithelium as a central mediator of
ﬁbroblast responses during asbestos-induced
ﬁbrogenesis. Communication between the air-
way epithelium and underlying ﬁbroblasts and
smooth muscle cells via paracrine signaling
is referred to as the “epithelial mesenchy-
mal cell trophic unit.” Epithelial–mesenchymal
cell interactions also are postulated to play an
important role in the pathogenesis of asthema
(Ingram & Bonner, 2006). The epithelial–
mesenchymal cell trophic unit is likely impor-
tant to understanding the pathogenesis of
asbestosis. Epithelial cells produce a variety
of factors, including epidermal growth fac-
tor receptor (EGFR) ligands. Signaling through
EGFR on ﬁbroblasts was shown to play an
important role in asbestos-induced ﬁbrosis in
two major ways. First, EGFR ligands are pro-
duced by epithelial cells, and then function
through paracrine signaling to activate EGFR
and promote ﬁbroblast proliferation. Asbestos106 B. T. MOSSMAN ET AL.
exposure increases the expression of TGF-α
in the lung epithelium (Liu & Brody, 2001),
and TGF-α was fopund to play a critical role
in ﬁbrogenesis. For example, targeted expres-
sion of TGF-α using the SP-C gene promoter
causes spontaneous pulmonary ﬁbrosis in mice
(Hardie et al., 2004). Second, the EGFR is
a central conduit through which ROS medi-
ate their cell signaling effects on epithelial
cells, ﬁbroblasts, and other cell types (Shukla
et al., 2006), and cell proliferation and expres-
sion of early response (fos/jun) protoonco-
genes are diminished in EGFR kinase-deﬁcient
mice (Manning et al., 2002). ROS, such as
H2O2, produced by asbestos are also known to
transiently inhibit protein tyrosine phosphatase
(PTP) activity associated with dephosphoryla-
tion of EGFR. Inhibition of PTP by asbestos-
generated ROS produced prolonged activation
of EGFR in a “ligand-independent manner”
that activated a variety of intracellular signaling
cascades described next. The EGFR may repre-
sent a potential therapeutic target for asbesto-
sis, especially since blocking the EGFR with a
tyrosine kinase inhibitor signiﬁcantly reduces
pulmonary ﬁbrosis in rats (Rice et al., 1999).
Intracellular Signaling Cascades in
Asbestosis
The pathogenesis of asbestos-associated
ﬁbrosis involves the participation of a num-
ber of cell types and is characterized by an
early and persistent inﬂammatory response that
involves the generation of oxidants, growth fac-
tors, chemokines, and cytokines (Robledo &
Mossman, 1999). These mediators may also
contribute directly to cell injury, proliferation,
and ﬁbrogenesis. After interaction with cells,
asbestos ﬁbers trigger a number of signaling
cascades involving mitogen-activated protein
kinases (MAPK) and nuclear factor kappaB (NF-
κB). Activation of transcription factors such as
NF-κB and activator protein-1 (AP-1) may be
linked to increases in early response genes
(e.g.,c-jun,c-fos,fra-1)thatgovernproliferation,
apoptosis,andinﬂammatorychangesinthecells
of the lung (Heintz et al., 1993; Shukla et al.,
2003b). Cell signaling in response to asbestos
ﬁbers may occur with rapid kinetics. For exam-
ple, asbestos-induced EGFR phosphorylation,
a ligand-independent process, occurs within
minutes and leads to downstream MAP kinase
kinase (MEK) and subsequent MAPK activation.
Activated MAPK (e.g., ERK-1 and -2) translo-
cate to the nucleus and activate transcriptional
programs (Yuan et al., 2004). Recent studies
using a genetic mouse model showed that tar-
geting the MEK cascade in lung epithelium
inhibits proliferation and ﬁbrogenesis by croci-
dolite asbestos after inhalation (Manning et al.,
2008). Therefore, the EGFR–MEK–MAPK cas-
cade is likely an important target for therapeutic
intervention,asindicatedpreviously.Itisimpor-
tanttonotethatacellsignalingcascadeinitiated
by asbestos ﬁbers or asbestos-generated ROS
differs signiﬁcantly from the identical cell signal-
ing cascade initiated by an endogenous growth
factor or cytokine, and results in a completely
different phenotypic outcome. Activation of the
EGFR by TGF-α induces ﬁbroblast proliferation,
or epithelial cell differentiation, whereas activa-
tionofEGFRbyasbestosﬁbersalsoresultsinthe
production of inﬂammatory cytokines. This dif-
ferenceinbiologicresponsemightbeduetothe
fact that growth factors produce transient phos-
phorylation of EGFR, whereas asbestos ﬁbers
(as well as certain metals) induce prolonged
phosphorylation of EGFR (Zanella et al., 1996).
Therefore, timing might be the key to under-
standinghowasbestosﬁbersproducepathologic
effects in the lung.
In summary, ROS generated by asbestos
exposure or asbestos–cell interactions may
serve as signaling intermediates to activate
intracellular signaling targets, including recep-
tor tyrosine kinases, MAPK kinases, and tran-
scription factors. These signaling intermediates
drive transcriptional activation and the up- or
downregulation of genes involved in inﬂamma-
tion and ﬁbrosis.
PROBLEMS IN INTERPRETATION OF
PAST STUDIES AND SUGGESTIONS
FOR FUTURE WORK
1. In review of the literature, it is often dif-
ﬁcult to evaluate the exposure or dose ofPULMONARY EFFECTS OF ASBESTOS 107
asbestos administered to rodents in compar-
ison to human exposures. Often the bivari-
ate size distribution of the ﬁbers, whether
dose-response was evaluated, and the route
of exposure are not reported in the study.
The expression of ﬁber dosimetry is often
the weakest component in studies. Many
studies report only gravimetric concentra-
tion or doses, with no information provided
on ﬁber number or bivariate ﬁber size distri-
bution. The latter is of particular importance
in differentiating effects of various types of
ﬁbers as ﬁber length is related to potency.
2. Dose-response studies are lacking in most in
vivo and in vitro studies. The large major-
ity of earlier inhalation exposure studies and
many of the more recent studies were per-
formed at high “overload” doses. Further,
there are few quantitative data presented
in past publications on nonﬁbrous particle
content of test ﬁber preparations. Since non-
ﬁbrous particles contribute to lung overload
(Oberdorster, 1995a), particle/ﬁber dimen-
sions need to be comprehensively evalu-
ated in materials used in future studies.
Moreover, well-designed inhalation studies
need to be performed in the range of con-
centrations of human exposures or within
one or two orders of magnitude. In addition,
it is important to include dose-response
studies with multiple exposure levels.
3. Well-characterized reference samples of
various types of asbestos and SVF need to
be obtained and provided to investigators in
the ﬁeld, as older reference samples (UICC,
NIEHS) are in general depleted and may
be altered or contaminated after decades of
storage.
4. The mode of action (MOA) of various
types of asbestos and naturally occurring
asbestiform or SVF ﬁbers may be different
in various lung and pleural diseases and
likely related to multiple characteristics of
ﬁbers. In addition, the relevant doses, sizes,
and other characteristics of ﬁbers may be
different in elicitation of individual toxic
and other phenotypic/genetic changes crit-
ical to the development of mesothelioma,
lung cancers, and ﬁbrosis. Experiments to
decipher these variables are needed and
will beneﬁt from multitiered approaches to
resolve these questions.
DEFINITIONS
Genotoxicity: Property of an agent for alter-
ing the genome of cells resulting in cell death
or altered function and division of cells, includ-
ing alterations in the genetic material, e.g.,
sister chromatid exchanges, transferred to cell
progeny.
Mutagenicity:P r o p e r t yo fa na g e n tt oc a u s e
alterations in the genome that are transferred
to cell progeny and subsequent generations.
Carcinogenicity: Property of an agent to
alter the genome and/or cellular control pro-
cesses resulting in uncontrolled cell prolif-
eration and other functional or phenotypic
changes that in turn result in malignant cancers.
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